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ABSTRACT 
Tobacco use is one of the primary factors for global burden of disease 
and often results in life-long nicotine addiction, only a small percentage 
users are able to maintain cessation. The life-long addiction together with 
a high relapse risk might be connected to drug-induced altered neural 
circuits. However, there is still uncertainty concerning the mechanisms 
involved in the progressive changes of neuronal function induced by 
repeated nicotine exposure. The rewarding effects of nicotine have been 
attributed to increased dopamine (DA) levels in the nucleus accumbens, 
(nAc) after stimulation of nicotinic acetylcholine receptors (nAChRs) in 
the ventral tegmental area (VTA). To explore long-term and age-
dependent effects by nicotine, Wistar rats were exposed to nicotine daily 
for three weeks, followed by different withdrawal periods after which 
locomotor stimulatory effects and behavioral disinhibition were assessed 
by means of activity boxes and the elevated plus-maze, respectively. In 
addition, neurotransmission was studied in brain slices from the nAc 
utilizing field potential recordings and whole-cell patch clamp. 
Histological procedures were also used for estimation of dendritic spine 
density. The results show that nicotine-induced locomotor sensitization is 
sustained for up to seven months, concomitant with decreased synaptic 
 function in nAc and increased response to the dopamine D2 receptor 
agonist quinpirole in nAc shell. We demonstrate that young animals 
display a faster response to nicotine and rapid tolerance development to 
the rearing depressing effect of nicotine. In addition, young animals 
exhibited lowered accumbal synaptic activity ten days into withdrawal. 
Moreover, nicotine induces behavioral disinhibition that is not fully 
developed until three months into withdrawal. These behavioral effects 
develop in parallel with changes in accumbal synaptic activity, 
GABAergic transmission and spine density. In addition, gene expression 
of GABAA receptor subunits is altered at this time point. Finally, we 
show that local manipulation of GABAergic transmission in the nAc in 
drug naïve rats results in disinhibitory behavior. In conclusion, limited 
exposure to nicotine causes long lasting to chronic alterations in behavior 
and accumbal neurotransmission. In particular the response to 
dopaminergic and GABAergic acting drugs is not fully developed until 
after extended abstinence. 
Keywords: Abstinence, Dopamine, Elevated plus-maze, GABA, 
Inhibitory control, Nicotine, Nucleus Accumbens, Sensitization 
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i 
SAMMANFATTNING PÅ SVENSKA 
”Nikot insensibi l i ser ing och e f f ekterna av långvarig abst inens -  
s tudier  av beteende,  neurokemi samt e l ektro fys io log iska förändringar 
i  råt ta” 
Beroendesjukdomar, till exempel nikotinberoende, är kroniska tillstånd 
som orsakar mycket fysisk och psykisk ohälsa, och samhällskostnaderna 
för tobaksrelaterade sjukdomar i Sverige är enorma. Detta beror till stor 
del på tobakens beroendeframkallande ingrediens, nikotin, som försvårar 
konsumtionsstopp. Trots att mycket forskning bedrivits kring nikotinets 
beroendeframkallande effekter har de idag tillgängliga behandlingarna 
mot nikotinberoende en begränsad effekt, och en stor majoritet återfaller 
i missbruk. Nikotin är en mycket potent drog med snabb 
toleransutveckling till drogens aversiva egenskaper, såsom illamående och 
takykardi. Men även de stimulativa egenskaperna hos drogen, som ökad 
vakenhet och koncentrationsförmåga, försämras med upprepad 
konsumtion. Efter ett långvarigt bruk krävs närvaro av drogen för att 
återställa dessa funktioner till en normal nivå.  
Beroendeframkallande droger aktiverar det mesolimbiska 
dopaminsystemet, vilket resulterar i frisättning av dopamin (DA) i 
striatala regioner i hjärnan, såsom nucleus accumbens (nAc), som är i 
fokus för denna avhandling. Dessa nervbanor är del av hjärnans 
belönings- och motivationssystem, vilka är avgörande för artens 
fortlevnad, då de förmedlar belönande känslor vid mat- och dryckesintag, 
samt vid sex. Av denna anledning är dessa nervbanor konserverade 
genom evolutionen och återfinns även hos lägre stående arter, vilket 
möjliggör en användning av råtta som modellorganism. I denna 
avhandling har Wistar råttor exponerats för nikotin dagligen i tre veckor 
och under dessa veckor har djurens lokomotoriska aktivitet studerats. 
Detta då många droger orsakar något som kallas sensibilisering, vilket 
innebär att den lokomotoriskt stimulerande effekten av en given dos av 
drogen ökar över tiden. Detta är ett välkänt men ännu ej mekanistiskt 
förklarat fenomen. I avhandlingen studeras bl.a. hur långvarig denna 
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nikotinsensibilisering är och resultaten visar att nikotin ger upphov till i 
det närmaste kroniska förändringar, då en tydlig effekt uppmättes i djuren 
ända upp till sju månader efter senaste nikotinexponering. Detta anses 
vara en mycket lång tid i en råttas liv, då dessa djur ofta inte lever längre 
än ca 2 år. Vid samma tillfälle fann vi att det elektrofysiologiska svaret på 
en DA-receptor-stimulerande drog (quinpirole) hade förstärkts. Vi har 
också studerat vilken betydelse ålder vid första exponering har för 
nikotinets effekter. För dessa försök användes djur i tre olika åldrar. 
Resultaten visar att yngre djur har både snabbare toleransutveckling och 
sensibilisering än äldre djur. Äldre djur verkar å andra sidan få en mer 
långvarig DA-frisättning i nAc efter nikotin. 
För att förstå mer i detalj vad som händer under abstinensfasen och vilka 
system i hjärnan som påverkas, förutom det dopaminerga, gjordes försök 
där vi i tre månader efter avbruten nikotintillförsel följde djurens 
undersökande beteende i en modell där detta undertrycks av ett aversivt 
stimulus (en öppen, upphöjd miljö). Vi fann att efter tre månaders 
abstinens från nikotin var dessa djur mer disinhiberade i sitt beteende 
jämfört med djur som endast fått kontrollbehandling (koksalt), ett resultat 
som kan tolkas som ökad impulsivitet, något som även rapporterats hos 
rökare. Vid samma tidpunkt hade djuren en förändrad neurotransmission 
i nAc, i synnerhet i det GABAerga systemet, vilket ej var fallet tidigare 
under abstinensen. GABA är ett hämmande system som ofta beskrivs 
som bromsen i hjärnan, och vid manipulation av detta system kan man 
påverka t.ex. impulsivt beteende. Dock brukar nAc ej anses vara en 
nyckelregion för denna typ av beteende. För att undersöka om förändring 
av GABAerg transmission i nAc skulle kunna ligga bakom den 
disinhiberande effekten utfördes försök där en GABAergt verkande 
substans (bensodiazepinen diazepam) injicerades lokalt i nAc på djuren. 
Detta ökade kraftigt djurens disinhiberade beteende. Vi kunde också 
påvisa att tätheten av s.k. ”dendritiska spines” var förändrad vid denna 
tidpunkt. Spines är små utskott på nervceller där synapser återfinns och 
en förändrad täthet av dessa tyder också på en förändrad 
neurotransmission. 
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I nAc är ca 95 % av neuronen GABAerga och uttrycket av GABAA-
receptorer är högt. Dessa reglerar cellaktivitet, och bl.a. dopaminnivåerna 
lokalt i nAc bestäms av aktiviteten i GABAA-receptorer. Alkohol utövar 
delar av sina effekter via detta system, liksom bensodiazepiner (lugnande 
preparat), som också har en missbrukspotential. Sammantaget är det 
GABAerga systemet ett mycket viktigt system, och små förändringar i 
dess reglering kan ha stora konsekvenser för övriga regioner med vilka 
nAc kommunicerar. Slutligen, nikotin initierar förändringar i det 
GABAerga systemet, som först efter en längre tids drogfrihet är fullt 
utvecklade. Dessa förändringar kan bidra till ett förändrat svar på andra 
droger som också verkar via detta system.  
Sammanfattningsvis tyder avhandlingens resultat på att en relativt 
kortvarig exponering för nikotin (tre veckor) leder till mycket långvariga 
förändringar både i beteende och i neurotransmission, samt att nikotin 
påverkar synapsfunktion i nAc och att unga individer ter sig mer känsliga 
för dessa effekter. 
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INTRODUCTION 
Brief overview of this thesis 
This thesis concerns the behavioral and neurophysiological effects of 
repeated nicotine exposure, extended nicotine abstinence, and the 
influence of age at first nicotine exposure. The present work is based on 
three papers, where the first two are published and paper III is a 
submitted manuscript. These are included as an appendix and referred to 
in Roman numerals (I-III) in the text 
Nicotine addiction and reward pathways 
Tobacco (Nicotiana tabacum) has been used as a recreational drug in the 
Americas since long before European explorers introduced it in the old 
world in mid 16th century (Fletcher, 1941). After introduction in Europe 
it rapidly gained in popularity, and in the early 17th century tobacco was 
believed to serve as a panacea, which contributed to making it the first 
crop to be grown for trade purposes in the 17th century (Wroth and 
Dickson, 1955).  
Nicotine: use and abuse 
Nicotine, the active and highly addictive component in tobacco, is a 
volatile alkaloid that forms salts with most acids. Today, nicotine is one 
of the most used and abused drugs in the world, with an estimate of 1 
billion smokers worldwide (WHO, 2015). Since the 1950s, when reports 
of the hazardous effects of smoking surfaced, there has been a yearly 
decline in users. Nevertheless, around 6 million people are still killed 
yearly in tobacco-related diseases, such as lung cancer and cardiovascular 
diseases. The annual cost for tobacco-related illness today in Sweden is 
estimated to 30 billion SEK, and smoking is the foremost preventable 
cause of illness and premature death in the world (Rostron et al., 2014; 
SverigesRegering, 2016). Due to the addictive properties of nicotine, few 
Nicotine sensitization and the effects of extended withdrawal 
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users are able to maintain nicotine cessation for longer periods of time, 
even though the negative consequences of smoking are well known.  
Addiction  
Drug dependence and addiction are chronic and relapsing brain disorders 
that can be devastating for the afflicted person, with features such as loss 
of intake control, compulsive drug seeking and incapability to stop taking 
the drug (Koob and Le Moal, 2008). The molecular principles behind 
addiction have been intensely researched over the last decades, but even 
though the knowledge of the disease has substantially increased,  the 
mechanisms by which an addiction is shaped are still largely unknown. 
These types of diagnoses lack exact physiological measures; instead 
diagnosis relies on a combination of symptoms that are described in 
diagnostic manuals (e.g. ICD 10: International Classification od Disease 
10th edition, or the DSM-V: Diagnostic and Statistical Manual of Mental 
Disorders, 5th edition).  
The transition from recreational drug use to an addiction can take years 
to develop, but for some individuals it can be a rapid process. The 
discrepancy between individuals is both due to genetic and environmental 
factors (Liu et al., 2004). The choice of drug also has an important role 
since different drugs have different addictive profiles, with heroin and 
methamphetamine being very addictive, whereas e.g. ecstasy and LSD 
have a less addictive profile (Nutt et al., 2007). Tobacco abuse is classified 
as a substance abuse disorder according to the criteria listed in Table 1, 
and even tough it lacks some features that are present in other substance 
abuse disorders, such as substance intoxication, it does share properties 
such as psychological and physiological withdrawal symptoms. 
Julia Morud Lekholm 
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Table 1. The DSM-V states that if at least two of the above listed criteria are present 
during the last 12 months the patient has a substance abuse disorder. The more criteria 
that are fulfilled, the more sever the addiction is. 
Physiological principles for addiction 
The brain reward system 
An addict’s inability to stop consuming the drug is in large parts 
explained by a drug-induced malfunction of the brain reward system. 
This system regulates reward and motivation, which are essential 
components for the survival of species. Intake of food and fluids serves 
as rewarding agents along with social interactions and sex. Due to its 
importance for the survival of species, it has been conserved throughout 
evolution and can be found in more simple species such as rodents and 
fruit fly, Drosophila Melanogaster (Waddell, 2013). This provides model 
systems to enable preclinical manipulations and characterization of the 
1. Tobacco is often taken in larger 
amount or over a longer period 
than was intended. 
2. There is a persistent desire or 
unsuccessful efforts to cut down 
or control tobacco use. 
3. A great deal of time is spent in 
activities necessary to obtain or 
use tobacco. 
4. Craving to use tobacco. 
5. Recurrent tobacco use resulting 
in failure to fulfill major role 
obligations at work, school or 
home. 
6. Continued tobacco use despite 
having persistent or recurrent 
social or interpersonal problems 
caused by the effects of tobacco 
(e.g. arguments with others 
about tobacco use). 
7.  Important social , occupational 
or recreational activities are 
given up or reduced due to 
tobacco use. 
8. Recurrent tobacco use in 
situations in which it is 
physically hazardous (e.g. 
smoking in bed). 
9. Tobacco use is continued 
despite knowledge of having a 
persistent or recurrent physical 
or physiological problem that is 
likely to have been caused or 
exacerbated by tobacco. 
10. Tolerance, as defined by either 
of the following: 
A: A need for markedly 
increased amount of tobacco to 
achieve the desired effect. 
B: A markedly diminished effect 
with continued use of the same 
amount of tobacco. 
11. Withdrawal, as manifested by 
either of the following: 
A: The characteristic withdrawal 
syndrome for tobacco  
B:  Tobacco or related 
substances such as nicotine are
DSM-5 chriteria for tobacco addiction
consumed for avoidance of  withdrawal
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system. The brain reward system comprises of several brain regions, such 
as the medial forebrain bundle, ventral tegmental area, striatal regions, 
raphe nuclei, septal regions, amygdala and prefrontal cortex areas to 
mention a few (Wise, 1996) (Fig. 1). These regions were identified in the 
early 1950’s when Olds and Milner discovered that rats learned to prefer 
locations that had been paired with electrical stimulation of specific brain 
areas (Olds and Milner, 1954). They continued to demonstrate that rats 
could learn to self-administer electrical stimulation into septal regions to 
such an extent that natural rewards, such as feeding and drinking, were 
abolished. Shortly after this discovery it was also confirmed that animals 
would self-administer drugs of abuse in the same manner as previously 
demonstrated with intracranial electrical self-stimulation (Schuster and 
Thompson, 1969). 
 
Figure 1. Graphical example of a simplified version of the reward pathways in rats, 
describing the major glutamatergic (brown), GABAergic (light green) and dopaminergic 
(purple) pathways. Abbreviations: mPFC: medial prefrontal cortex, nAc: nucleus 
accumbens, LHab: lateral habenula, LH: lateral hypothalamus, VTA: ventral tegmental 
area, LDTg: lateral dorsal tegmentum. Image adapted from (Russo and Nestler, 2013). 
mPFC
Dorsal
striatum
nAc
Amygdala VTA
LH LDTg
Dopaminergic
GABAergic
Glutamatergic
LHab
Hippocampus
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The mesolimbic dopamine system and nucleus accumbens 
In 1958, Carlsson and colleagues discovered that dopamine (DA) is a 
neurotransmitter in its own right (Carlsson et al., 1958). Subsequently, 
histological studies demonstrated that DA and other monoamines were 
located to discrete sets of neurons with their cell bodies in the midbrain 
(Carlsson et al., 1964; Dahlstrom and Fuxe, 1964). The highest density of 
dopaminergic cell-bodies were found in the ventral midbrain which 
encompasses the ventral tegmental area (VTA) and the substantia nigra. 
Neurons originating in the VTA project to a number of limbic areas and 
is thus called the mesolimbic DA system. This system has been 
implicated to be directly or indirectly involved in a wide range of 
behaviors, including the rewarding and positive reinforcing effects of 
drugs of abuse, attention and motivation, and motor control (Berridge, 
2012; Schultz, 2006; Wise, 1996). The nigrostriatal system, on the other 
hand, has been more implicated in motor-activating effects (Obeso et al., 
2008; Trudeau et al., 2014).  
Dopaminergic neurons exhibit two signature firing-patterns: a phasic 
burst firing and a regular tonic single-spike dependent firing (Grace and 
Bunney, 1984a, b). The positive reinforcing function is primarily 
associated with phasic burst-dependent firing, whereas the motor 
function is more related to stabile tonic firing (Marinelli and 
McCutcheon, 2014). The DA neurons in VTA have projections that run 
via the medial forebrain bundle into frontal areas such as the ventral 
striatum - also known as the nucleus accumbens (nAc), the frontal cortex, 
septum and the olfactory tubercle, but they also project to other areas 
such as the hypothalamus, hippocampus and the amygdala (Trudeau et 
al., 2014). Based on this it can easily be understood that axons of the DA 
neurons are heavily branched and a single neuron might give rise to 
300,000 axon terminals (Arbuthnott and Wickens, 2007),  implying that 
manipulations of DA neurons might produce very complex and 
multiregional effects. 
The nucleus accumbens (nAc) is a relatively small region in the basal 
ganglia that mainly consists of GABAergic neurons. The majority are 
Nicotine sensitization and the effects of extended withdrawal 
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medium spiny neurons (MSNs), which are projecting neurons containing 
either dopamine receptor 1 (D1) or dopamine receptor 2 (D2) receptors 
and mediating excitatory and inhibitory neurotransmission, respectively 
(Vicente et al., 2016). These neurons project to regions such as the lateral 
habenula and the VTA (Russo and Nestler, 2013). The nAc responds to 
hedonic, novel and aversive stimuli (Everitt, 1990; Salamone, 1994; 
Schultz et al., 1997) and can be divided into several subregions. A 
division into a core and shell region is the most commonly used 
(Floresco, 2015).  
The shell region is part of the extended amygdala whereas the core region 
has more similarities to the dorsal part of the striatum (Alheid and 
Heimer, 1988). DA in the nAc core has been suggested to be involved in 
gaining control over amygdala-dependent appetitive learning, and lesions 
of the core do not affect Pavlovian conditioning. DA in nAc shell, on the 
other hand, has been implicated in hippocampal-dependent spatial 
information processing, and lesions here influence instrumental and 
Pavlovian learning (Corbit et al., 2001; Ito and Hayen, 2011).  
Regulation of the nucleus accumbens 
The organization of cells within the nAc is different from most brain 
regions, since it completely lacks a laminar organization. Instead the 
MSNs are organized in mosaic patches, these patches also represent 
different compartments of input-output segregations (Voorn et al., 1989). 
Interestingly, this organization appears to be represented even on a 
receptor localization level (Gerfen, 1992). Depending on the receptor 
expression on the MSNs in nAc they can either be part of the excitatory 
direct pathway (D1 containing), which directly innervates the VTA, or the 
inhibitory indirect pathway (D2 containing), that regulates VTA through 
intervening GABAergic neurons in the ventral pallidum (Russo and 
Nestler, 2013; Vicente et al., 2016).  
There is also a small population of cholinergic and GABAergic 
interneurons that even though low in numbers have an important 
regulatory function on accumbal activity. The precise mechanisms by 
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which cholinergic interneurons regulate accumbal function are not 
known, but they can regulate striatal output rapidly by controlling GABA 
release from dopaminergic terminals (Nelson et al., 2014). Fast spiking 
GABAergic interneurons can inhibit MSNs directly by postsynaptic 
inhibition whereas the MSNs themselves can inhibit basal ganglia output 
and form functional synapses through local axonal connections (Tunstall 
et al., 2002). Together these different pathways form striatal 
microcircuits, having their own separate functions (Tepper and Plenz, 
2006). The nAc also receives a substantial glutamatergic input from areas 
such as the prefrontal cortex, hippocampus and amygdala (Russo and 
Nestler, 2013). 
Drugs of abuse and accumbal dopamine 
Most drugs of abuse produce a large increase in accumbal DA after 
systemic injections; nicotine is no exception (Koob and Volkow, 2016). 
Self-administration of drugs will also release DA in nAc (Ikemoto and 
Bonci, 2014) and this behavior can be attenuated via DA antagonists or 
by destruction of DA neurons (Corrigall and Coen, 1991; Corrigall et al., 
1992), with a few drugs, such as ethanol and opiates, as exceptions  
(Dworkin et al., 1988; Pettit et al., 1984; Rassnick et al., 1993). It has been 
suggested that DA is required for the establishment of ethanol self-
administration (Ikemoto et al., 1997), whereas once established it may not 
be critical for maintaining ethanol self-administration (Ikemoto et al., 
1997; Rassnick et al., 1993). Interestingly, low doses of DA antagonists 
increase drug self-administration, which is often interpreted as a 
compensatory increase in intake due to a blunted drug response (Di 
Chiara and Bassareo, 2007; Yokel and Wise, 1975).  
The mechanisms underlying nicotine-induced DA increases differ from 
those of many other drugs of abuse, e.g. cocaine and amphetamine that 
act directly on the dopaminergic transporters located on the neuronal 
terminals. Nicotine exerts its DA increasing effect by several parallel 
mechanisms, such as stimulation of nAChRs situated on DA neurons in 
VTA, or by increasing glutamatergic excitation and altering the influence 
of GABAergic inhibition on DA neurons (Pidoplichko et al., 2004; 
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Schilstrom et al., 1998; Tolu et al., 2013). The GABAergic influence over 
nicotine-induced DA release is very complex since the GABAergic 
neurons of the VTA are not strictly interneurons. There are also 
GABAergic neurons projecting to same frontal regions, as do DA 
neurons (Omelchenko and Sesack, 2009). Cholinergic modulation of 
GABAergic interneurons in the VTA is also very important for 
spontaneous baseline DA burst firing (Tolu et al., 2013). Additionally, 
nicotine effects mediated via nAChRs are receptor subunit dependent 
since receptors with different subunit configurations behave differently 
when exposed to nicotine, some desensitize rapidly at low concentrations 
whereas some are more robust (Pidoplichko et al., 1997; Pidoplichko et 
al., 2004). 
Drug dependence and impulsive behavior 
Impulsivity is a multidimensional concept that can be dissected into 
several components of behavior, such as behavioral disinhibition and 
impulsive choice, e.g. delayed monetary reward in humans. Overall 
impulsive behavior can be described as acting prematurely and an 
inability to constrain inappropriate behaviors. According to the DSM V 
several criteria for nicotine dependence, or drug dependence in general, 
include components of impulsive behavior (Table 1). There is an 
increasing body of evidence both in animal studies and human 
experiments that stimulants, such as nicotine, induce impulsive behavior 
(Ericson et al., 2000; Fields et al., 2009; Fillmore et al., 2002; Kolokotroni 
et al., 2011; Olausson et al., 2001b; Paine and Olmstead, 2004). This has 
implications for the interpretation of the DSM V criteria, since the drug 
use itself will cause heightened impulsivity and as such, fulfill some of the 
listed criteria. In addition, individuals who exhibit impulsive traits are 
overrepresented among drug users, and due to this, impulsivity has been 
identified as an important risk factor for the development of drug abuse 
as well as for relapse (Tomko et al., 2016).  
In the past, regions such as the prefrontal cortex and the amygdala have 
been considered to be central for regulating impulsive behaviors, but 
recent evidence also implicates nAc as an important region for 
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controlling impulsive behaviors (Feja et al., 2014). Also, DA together 
with noradrenaline have been considered to be central for impulsive 
behaviors, but recent data also suggest a role for GABAergic 
transmission in regulating these types of behaviors (Hayes et al., 2014).   
Nicotine and nicotinic acetylcholine receptors 
Nicotine was isolated from the leaves of the tobacco plant already in 
1828 by the two German chemists Posselt and Reimann, who thought of 
nicotine as a poison (Posselt, 1828). At the turn of the 20th century new 
hypotheses on how neurons were stimulated by different substances 
emerged. The assumption that neuronal active substances acted directly 
on nerve endings was proven wrong after works by Langley and 
colleagues (Langley, 1901, 1918). Nicotine was used as the model 
substance in their work that led up to the identification of “receptive 
substances” – receptors. The nicotinic acetylcholine receptors (nAChRs) 
were thereby among the first receptors to be studied. 
 
Figure 2. A descriptive image of the heteromeric α4β2 and the homomeric α7 
pentameric nicotinic acetylcholine receptor, showing discrete ligand binding-sites and 
that they have different ion permeability.  
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The nicotinic acetylcholine receptor and its pharmacology 
In the 1980s it was confirmed that nAChRs existed in the CNS, that 
these were different from previously studied neuromuscular receptors, 
and that they contributed to the psychoactive properties of nicotine in a 
subunit-dependent manner (Caulfield and Higgins, 1983; Clarke and Pert, 
1985; Clarke et al., 1984). The use of α-bungarotoxin, a neurotoxin that 
binds irreversibly to nAChRs, was proven useful since it helped in 
identifying different subpopulations of the receptor (Clarke et al., 1986; 
Clarke et al., 1985). In CNS, α-bungarotoxin specifically binds 
homomeric α7, the only homomeric composition of neuronal nAChRs. 
The nAChRs have a pentameric structure (Fig. 2), which always consists 
of at least one alpha subunit. The different subunits represented centrally 
are eight α-type (α2-α7, α9-α10) and three β-type (β2-β4) subunits, which 
combined create a large variety in structure and function due to the many 
possible combinations (Zoli et al., 2015). The two most commonly 
expressed neuronal combinations are the low nicotine-affinity α7 
homomer and the high nicotine-affinity α4β2 heteromer (Dani, 2015). 
The rat midbrain DA neurons are generally believed to express the α3-α7 
and the β2-β3 subunits. Different subunit compositions are located either 
pre- or postsynaptically where the α7 homomer is most commonly, but 
not exclusively, presynaptic and the α4β2 are often located postsynaptic 
or somatic (Zhang et al., 2009). Different antagonists are available for the 
detection of different subunit compositions (e.g. MLA for α7 or α3/α6 
containing, and DhβE for α4β2), which have been used for decades to 
study the diverse function of nAChRs. 
The nAChRs are selectively permeable to cations in a subunit-dependent 
manner, and as such all compositions are permeable for influx of sodium 
and efflux of potassium, whereas the α7 homomer is also highly 
permeable for calcium (Albuquerque et al., 2009; Dani, 2001). This is due 
to the type of amino acids, and the charged residues, that line the inner 
and outer parts of the receptor pore (Bertrand et al., 1993). Calcium 
permeability has major impact on neurotransmission since high influx of 
calcium in to neurons activates intracellular signaling cascades, which 
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then influences the probability for neurotransmitter vesicle release. 
Additionally, nAChRs themselves are allosterically modulated by calcium 
so that high concentrations of calcium increase the probability for 
opening the channel (Vernino et al., 1992). 
Acute nicotine effects and receptor desensitization 
Immediately after tobacco is consumed, brain nicotine levels will increase 
rapidly and already at 20 nM the nAChRs will start to desensitize (Brody 
et al., 2006). In humans, prominent nAChR desensitization has been 
reported already after the consumption of one cigarette (Matta et al., 
2007). The high-affinity α4β2 nAChR is very sensitive to increased 
nicotine concentrations and will rather quickly be substantially 
desensitized, as compared to the low-affinity α7 that requires higher 
concentrations to be desensitized (Brody et al., 2006). The affinity of 
nicotine for the α4β2 receptor ranges between 0.5-14 nmol, which 
translates to 0.01-2.3 ng/ml, and a human smoker often has blood 
plasma concentrations of 10-50 ng/ml (Benowitz et al., 1990; Sihver et 
al., 2000). This indicates that in human smokers, the α4β2 nAChRs are 
most of the time completely saturated. This has consequences for 
GABAergic neurotransmission, since these receptors are mostly located 
on GABAergic interneurons, with implications for inhibition on DA 
neurons in the VTA. Desensitization is a conformational state of the 
receptor (together with “rest” or “open”), in which the receptor is not 
available for agonist stimulation (Quick and Lester, 2002). This state has 
been suggested to be either short-lived or long-lasting, partly depending 
on the nicotine exposure level (Khiroug et al., 1997) or the 
phosphorylation state (Khiroug et al., 1998). Long periods of low 
nicotine exposure will eventually create a very deep desensitization of the 
receptor that is difficult to reverse, a scenario similar to what happens in 
human smokers. This has effects on normal ACh activity at cholinergic 
synapses, since the availability of receptors is decreased - the synaptic 
response after ACh release will be blunted (Pidoplichko et al., 2004).  
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Chronic effects and behavioral sensitization  
The homeostatic response to nAChRs desensitization is receptor 
upregulation (Fenster et al., 1999; Picciotto et al., 2008), and it seems as if 
both chronic nicotine exposure and early withdrawal causes nAChRs 
upregulation (Staley et al., 2006). Long-term exposure to nicotine will 
increase the number of nAChRs binding sites on the cell surface.  It is 
not yet known whether this actually is due to an increased number of 
functional nAChRs, that still can be activated, or if it mostly represents 
desensitized and inactive nAChRs (Vallejo et al., 2005; Wonnacott, 1990).  
Repeated administration of stimulant drugs, such as nicotine, induces the 
phenomenon of behavioral sensitization, which implicates an increased 
drug-response over time to the same dose of drug in behaviors such as 
locomotion (Clarke and Kumar, 1983a). Sensitization can be viewed as 
the opposite of tolerance development, in which the drug response is 
decreased over time. The effect on locomotion has been suggested to 
partly derive from altered responsiveness of DA receptors in the nAc, 
which results in a hypersensitive receptor (Di Chiara, 2000; Molander and 
Soderpalm, 2003). This assumption is partly based on the observation 
that activation of accumbal postsynaptic DA receptors increases 
locomotion, while the opposite – antagonism or disruption of DA 
receptors/neurons – will attenuate this behavior (Clarke, 1990; Clarke et 
al., 1988). Although, increased receptor responsiveness has never been 
detected in the acute exposure phase, it appears to develop during the 
early withdrawal phase (Robinson and Berridge, 1993; Zhang et al., 2012).  
Age discrepancies 
Regular smokers have often had their first experience of nicotine at a 
young age, and nicotine’s rewarding and reinforcing properties appear to 
be age-dependent (Kendler et al., 2013). Thus, teenagers report stronger 
and more positive effects from smoking, both in terms of the rewarding 
feeling and a stronger addiction with a lower chance of cessation 
(DiFranza et al., 2000). Additionally, teenagers report fewer aversive 
effects at their first nicotine exposures, as compared to adults (DiFranza 
et al., 2000). One of the suggested mechanisms underlying these 
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phenomena is an increased sensitivity during adolescence of midbrain 
excitatory synapses on DA neurons, where nicotine will increase the 
AMPA/NMDA ratio of evoked EPSCs in both young and adult rats. 
Although, young animals require a much lower dose to produce the same 
magnitude in response as adults (Placzek et al., 2009). Animal studies 
have revealed that young rats are more sensitive to nicotine than adult 
rats, so as that young rats form a stronger place preference to nicotine, 
which has been suggested to be due to an increased nicotine-induced 
long-term potentiation in younger rats (Placzek et al., 2009). It also 
appears that small amounts of nicotine during adolescence will affect the 
response to nicotine later in life, as well as increase nicotine self-
administration (Adriani et al., 2003). In addition, early life exposure has 
been reported to alter nAChR subunit compositions resulting in an 
increased sensitivity to nicotine (Adriani et al., 2003).  
Nicotine as a gateway drug 
The gateway drug hypothesis refers to the notion that the use of “light 
drugs”, such as nicotine and alcohol, precedes the use of cannabis, which 
in turns precedes the use of “heavier drugs”, such as cocaine, 
amphetamine or heroine (Kandel, 1975). Epidemiological studies have 
supported this model, and nicotine appears to be of particular importance 
for the gateway process (Yamaguchi and Kandel, 1984). As was reported 
in the most recent U.S. National Survey on Drug Use and Health, a 
decline in tobacco use (40.8 % - 30.6 %) was detected in the US between 
years the 2002-2013; interestingly this was also the case for cocaine use 
(6.7 % - 4.4 %). While this could be due to sociological aspects, such as 
changes in drug policies or changes in law enforcement strategies, 
preclinical reports also support a connection between nicotine and 
cocaine. Pretreatment with nicotine in young mice increases the response 
to cocaine later in life, both in the form of increased drug-induced 
locomotion and a stronger conditioned place-preference (Levine et al., 
2011). The mechanism is partly believed to be through altered 
epigenetics, in which the expression of FosB is altered, resulting in 
reduced cocaine-induced LTP (long term potentiation) in the nAc. 
Nicotine has been described to prime the brain for subsequent drug use 
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by altering LTP (Huang et al., 2013). Interestingly, the effect is 
unidirectional, as pretreatment with cocaine does not influence nicotine-
induced LTP in the same manner (Huang et al., 2013).   
GABA and the GABAA receptor   
The GABAergic (γ-aminobutyric acid) system is the main inhibitory 
neurotransmitter system in mammalian brains, and approximately 20% of 
all neurons in the brain are GABAergic. These neurons can either be 
interneurons of different kinds or projecting neurons, such as the before 
mentioned MSNs of the striatum. The interneurons are often sparsely 
spiny, whereas the dendrites of the MSNs are dense with spines. 
The GABAA receptor and its pharmacology 
The mammalian GABA system is comprised of GABA receptors (A and 
B) and GABA releasing neurons. GABAergic receptors are very 
abundant in the brain, and are present on almost all neurons (Mody and 
Pearce, 2004). The GABAA receptors are ligand-gated ion channels that 
are permeable to chloride after activation, which will cause the cell to be 
hyperpolarized (Semyanov et al., 2003) (Fig. 3). The receptor shares some 
similarities to the nAChRs, in that they are pentameric structures with 
several possible subunit compositions (Fig. 3). The GABAB receptors act 
very differently, since they are g-protein coupled receptors of a 
metabotropic nature. 
The GABAA receptors can be located both synaptically and 
extrasynaptically (Soltesz et al., 1990), which indicates that they 
participate both in phasic inhibition, by producing inhibitory postsynaptic 
currents (IPSCs), and tonic inhibition on neurotransmission (Brickley and 
Mody, 2012). The charge produced by tonically activated GABAA 
receptors has been estimated to be up to three times the size of those 
produced by phasic events (Nusser and Mody, 2002). The difference 
between tonic and phasic GABAA receptors is in part due to different 
receptor subunit compositions, where the δ-unit appears important for 
tonically active receptors (Nusser et al., 1998). Receptors located 
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extrasynaptically are also more sensitive to low concentrations of the 
GABAA antagonist picrotoxin, which indicates a discrepancy between 
different classes of GABAA receptors in their pharmacological profile 
(Semyanov et al., 2003). 
 
 
 
 
 
 
 
 
 
Figure 3. A conceptual image of the heteromeric GABAA receptor, showing the 
endogenous ligand binding-site in green, as well as the allosteric binding site for 
benzodiazepines (BZD) in pink.  
The GABAA receptor has several different binding sites besides the main 
site for GABA, and GABA-influencing drugs such as benzodiazepines 
and barbiturates allosterically affect the receptor via interaction with their 
specific binding sites. More specifically, benzodiazepines influence the 
probability for the opening of the ion-channel and will thereby increase 
the influx of chloride in to the cell. The benzodiazepine effect is 
dependent on the presence of the endogenous ligand as opposed to 
barbiturates, which can influence the opening time of the channel on its 
own (Jembrek and Vlainic, 2015).  
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GABA, anxiolysis and impulsive behavior 
GABAergic transmission has for long been implicated in anxiety 
disorders (Perna et al., 2016). This is in part due to the profound 
anxiolytic effect produced by GABAA receptor acting drugs, such as 
benzodiazepines, which will increase GABAergic inhibition. 
Benzodiazepines will also produce a sedative and hypnotic effect, and the 
dissociation between these effects is not yet fully understood, but the 
involvement of specificity for different subunit compositions has been 
suggested (Chagraoui et al., 2016).  
In animal studies, anxiolytic-like behaviors have been validated using the 
elevated plus maze (detailed description in Methods), in which the animal’s 
activity on open, as opposed to closed, arms can be increased by systemic 
injections of benzodiazepines. However, this could also reflect a 
disinhibited, impulsive behavior, since an animal might still be anxious, 
even though it acts disinhibited towards an aversive stimulus. Consistent 
with this, GABAergic transmission has lately been suggested to be of 
importance for regulating also impulsive behaviors (Hayes et al., 2014). 
This is also true for nicotine, which repeatedly has been demonstrated to 
induce impulsive behaviors, both in the acute and chronic phase 
(Kolokotroni et al., 2011; Olausson et al., 1999; Olausson et al., 2001b). 
Traditionally, brain subregions such as the amygdala and prefrontal 
cortex have been attributed an important role in these types of behaviors, 
but recent evidence also imply the involvement of nAc (Feja et al., 2014).  
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OBJECTIVES 
Improved understanding of nicotine’s effects on neurotransmission, as 
well as, progressive neuronal changes that occur during nicotine 
abstinence may provide critical insight into the mechanisms that underlie 
addiction and could aid in developing adequate treatments. The overall 
aim of this thesis is to characterize nicotine-induced alterations in 
behavior and accumbal neurotransmission, some of which develop 
during the course of extended withdrawal.  
More specifically the objectives of this thesis are: 
• To investigate the longevity of nicotine behavioral 
sensitization and the ensuing alterations in dopaminergic 
transmission within the nAc (Paper 1) 
• To increase the knowledge of the importance of the age 
at first exposure for nicotine and the impact age has on 
nicotine effects (Paper 2) 
• To study the effects of extended nicotine withdrawal on 
accumbal GABAergic transmission, GABA-related 
behavior, and GABAA receptor subunit transcripts  
(Paper 3) 
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RESULTS AND DISCUSSION 
Nicotine causes chronic behavioral sensitization (paper I) 
Nicotine is known to increase locomotion after repeated administration, 
but the persistency of these alterations has previously not been 
investigated for periods longer than 4 weeks (Miller et al., 2001). The 
behavioral effects have in part been attributed to alterations in the 
dopaminergic system, which have been reported to be present after one 
week into abstinence and forward (Le Foll et al., 2003; Molander and 
Soderpalm, 2003). Also, suggestions to whether there is a regional 
discrepancy between the effects in the nAc core and shell have been 
made, where nicotine primarily has been reported to promote DA release 
in the core region (Benwell and Balfour, 1992; Cadoni and Di Chiara, 
2000).  
In order to test the longevity of nicotine-sensitization, and the 
localization of nicotine-induced alterations in dopaminergic transmission 
after extended withdrawal, rats were exposed to nicotine daily during 
three weeks. The behavior and accumbal transmission was assessed up to 
seven months into abstinence. The effects of a relapse episode were 
mimicked by re-exposure to nicotine seven months after cessation. 
Nicotine-induced locomotor sensitization sustains for up to seven months, together with effects in 
synaptic activity and the response to a DA D2 agonist 
We found that nicotine induces long lasting changes in behavioral 
sensitization (Fig. 4), as the effect could still be detected at the end point 
of the study - seven months into withdrawal. The maximum locomotor 
response was detected after nine weeks of abstinence (Fig. 4D), which 
could be an indication of a drug-incubation effect that previously has 
been reported for drugs such as cocaine (Grimm et al., 2001).  
After seven months of abstinence we also observed a depressant effect in 
synaptic activity, both in nAc core and shell (Fig. 5A-B), as measured by a 
stepwise increase of the stimulation strength. Interestingly, the response 
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to DA D2 receptor acting drugs has previously been reported to be 
altered in nicotine-sensitized rats (Olausson et al., 2001a). And since this 
could be part of the explanation for the long-lasting locomotor effect, the 
electrophysiological response to the DA D2 receptor agonist quinpirole 
was investigated. Interestingly, in the nAc shell, but not core, a significant 
increase in quinpirole response was observed (Fig. 5D). This could 
suggest that the two regions do not respond uniformly to nicotine 
exposure. The observed effect to quinpirole in the nAc shell could be due 
to an increased postsynaptic D2 receptor responsiveness in this region. 
 
Figure 4. Three weeks of nicotine exposure induces long-lasting effects in nicotine-
induced locomotion (A). The maximum response was observed after a brief abstinence 
period (D). After 15 to 27 weeks of abstinence the locomotor response appeared to 
have plateaued and no tendency to a decline was found after 27 weeks of abstinence (E). 
The present data from nAc core indicates a lack of effect of quinpirole in 
slices from nicotine-treated animals (Fig. 5E), and since previous reports 
have demonstrated the importance of nAc core after acute nicotine 
exposure (Cadoni and Di Chiara, 2000), the results could be suggestive of 
both a temporal and region-specific development. The dopaminergic 
alterations might thus be present in the core region in the acute phase 
and later re-localized to the shell region after an extended withdrawal 
period.  
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Moreover, data presented in this paper supports occurrence of specific 
differences in dopaminergic function within nAc subregions, possibly 
indicating a pharmacological specificity between shell and core. The lack 
of effect of quinpirole in nAc core is most likely not due to an overall 
lowly responsive system, since the synaptic activity was depressed in both 
subregions. The discrepancies in response between the two regions was 
also reflected on the probability for transmitter release, where the 
probability was significantly decreased in slices from nicotine animals in 
the shell region, whereas a tendency to an increase instead was seen in the 
core region (Fig. 5C). Together with the reduced synaptic activity, the 
effect on PPR in nAc shell could thus be related to a reduced expression, 
or function, of postsynaptic receptors. 
 
Figure 5. A-B) Depressant effects in synaptic activity were still present, both in nAc 
core and shell, 7 months after nicotine abstinence. D-E) The response to the DA D2 
receptor agonist quinpirole was both treatment- and region-specific, and a significant 
effect was observed in nAc shell of nicotine treated animals. A decreased probability for 
transmitter release was also observed in the shell of nicotine treated animals (C). The 
image describes a graphical representation of how the recording and stimulating 
electrodes were positioned in the nAc (F). 
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High receptiveness to re-exposure is reflected in changes of accumbal synaptic activity  
In order to mimic the effects of a relapse period we re-exposed animals 
to nicotine during six days after a seven-month abstinence period.  
Previously vehicle treated animals were also exposed to nicotine as an 
age-matched control. An immediate locomotor response was detected 
after the first nicotine injection in all animals, and after six days of 
treatment the previously nicotine treated animals responded with a higher 
level of stimulation than observed during the initial exposure period (see 
paper I, fig. 5). This was concomitant with a decreased synaptic activity as 
well as an increased responsiveness to quinpirole in slices from animals 
previously treated with nicotine (see paper I, fig. 6). This could indicate that 
the dopaminergic alterations produced by previous nicotine treatment are 
very robust and also easily boosted at re-exposure to the drug. This is in 
line with human studies that describe a heightened drug sensitivity after 
extended withdrawal, due to persistent drug sensitization (Miller et al., 
2001), and could be a phenomenon related to the high relapse risk 
observed after minimal nicotine exposure in previous smokers (Brigham 
et al., 1990). In addition, a lack of effect was seen on transmitter release 
in both groups, which could indicate a discrepancy in how nicotine 
modulates synaptic activity in short and long-term manners. And even 
though repeated nicotine administration induces effects in synaptic 
activity, this is not necessarily concomitant with altered transmitter 
release. 
In conclusion, the data obtained suggests that a limited period of nicotine 
exposure induces very long-lasting alterations, both in locomotion and 
accumbal transmission in the rat. In addition, the response to the DA D2 
receptor agonist quinpirole is specifically altered in the nAc shell region 
after seven months of abstinence. Moreover, after an extended 
withdrawal period the nicotine-treated animals are very sensitive to re-
exposure, which was displayed as a more rapid drug response - both in 
behavior and accumbal neurotransmission. 
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Age at first nicotine exposure influences both stimulatory response and 
accumbal neurotransmission (paper II) 
The risk for developing a more severe nicotine addiction is increased if 
the first nicotine exposure occurs during adolescence (Breslau and 
Peterson, 1996). This is partly believed to be due to the differences in the 
perceived reward sensation and reinforcing effect between adults and 
adolescents (Shram et al., 2006). Teenagers also report less aversive 
effects from nicotine than adults (DiFranza et al., 2000). Animal studies 
have reported an increased sensitivity of excitatory synapses in the 
midbrain of young animals, in which the nicotine-induced effect on 
eEPSCs are increased (Placzek et al., 2009). In addition, an increased 
firing of cholinergic neurons in the lateral tegmental nucleus has been 
reported in young rats (Christensen et al., 2014). Adolescent rats also 
display an increased nicotine metabolism (Vieira-Brock et al., 2013), 
which substantially could influence the effects of the drug.  
In light of this we wanted to investigate the influence of age on nicotinic 
effects, more specifically on behavioral alterations and accumbal 
neurotransmission. We also tested if nicotine-evoked DA release was 
influenced by age in nAc of drug naïve animals. 
Increased behavioral sensitization and tolerance development in young animals 
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Figure 6. A-C) Nicotine influences locomotion in an age-dependent manner, displayed 
as faster behavioral sensitization development in young animals. D-E) The nicotine-
induced depressant effect on rearing is influenced by age and the development of 
tolerance to these depressant effects is slower in old animals.  
Locomotion and rearing behavior were assessed in Wistar rats during a 
three-week period with daily nicotine injections. The onset of behavioral 
sensitization was very rapid in the two younger age groups (Fig. 6A-B), 
whereas in the older group a significant effect was not established until 
completion of the three-week treatment period (Fig. 6C). At this time 
point the total activity in nicotine treated old rats was substantially lower 
than the activity of the younger groups, although the activity in the 
control groups were very similar throughout the groups.  
An interesting finding regarding the development of tolerance to the 
aversive effects of nicotine was done looking at rearing behavior. In drug-
naïve rats nicotine induces an acute depressant effect on rearing activity. 
Interestingly, nicotine is known to also induce ataxia in non-tolerant 
subjects (Clarke and Kumar, 1983b). However, the rearing activity is 
rapidly regained and after two weeks of treatment often instead increased 
in nicotine-treated animals. This pattern was observed in the two younger 
age groups (Fig. 6D-E), but the opposite was found in the old animals 
where the controls instead were performing significantly more rearing 
after two weeks of treatment (Fig. 6F). This could indicate that tolerance 
development, or simply neuronal adaptations, to nicotine develop slower 
at an older age, which would render young individuals more susceptible 
to nicotine. Interestingly, rearing activity has also been correlated with 
local DA levels in nAc, in which high levels of DA have been linked to 
high rearing activity (Thiel et al., 1999), which could suggest that young 
animals experience higher levels of accumbal DA after repeated nicotine 
exposure.  
Nicotine sensitization and the effects of extended withdrawal 
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Nicotine influences synaptic activity together with dopamine output in drug-naïve rats in an age-
dependent manner 
 
Figure 7. Different aspects of nicotine-induced effects were investigated in both 
nicotine-treated and nicotine-naïve animals. Three weeks of nicotine treatment 
specifically depressed synaptic activity in young animals after ten days of nicotine 
withdrawal (A). In nicotine-naïve animals DA release was estimated by microdialysis, 
indicating a prolonged DA effect in old animals (D). When measured by field-potential 
recordings the excitatory response to nicotine was specifically depressed in juvenile rats 
(E). 
Estimation of synaptic efficacy in nAc was assessed after ten days of 
nicotine withdrawal, following a three-week treatment period. This 
revealed an age-dependent effect, since a significant synaptic depression 
was detected specifically in slices from nicotine-treated juvenile rats (Fig. 
7A), whereas a lack of effect was seen in the other age groups. Moreover, 
in slices from nicotine-naïve animals only the juvenile group displayed a 
depressive effect on excitatory output after acute nicotine exposure (Fig. 
7E).  
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Since the age-dependent effect in locomotion and rearing might be linked 
to differences in nicotine-evoked accumbal DA, the dopaminergic output 
was estimated by in vivo microdialysis in drug-naïve animals at three 
different ages. Even though the results show a lack of effect on the 
maximum response to nicotine, a significantly sustained DA elevation 
was seen in the oldest age group. This could be suggestive of age-
dependent changes in DA receptor or dopaminergic transporter 
expression (Rahman and McBride, 2002), or a reduced feedback control 
of mesolimbic DA release from the nAc (Rahman and McBride, 2002). A 
low receptor expression could influence the progress of both the 
development of behavioral adaptations and the acute nicotine-induced 
DA output.  
However, since nicotine-evoked DA release was very similar across the 
age groups, the changes detected in synaptic activity (Fig. 7A) and DA 
release cannot be directly linked. Rather, the effect seen in field-potential 
recordings, where only slices from drug-naïve juvenile animals displayed 
an effect, suggest that neurotransmission in this age group is easily altered 
and that the neural circuits might be extra sensitive to drug stimuli at this 
young age.  
In conclusion we report an increased sensitivity to nicotine, both with 
respect to behavior and accumbal transmission, in juvenile and adolescent 
animals, as compared to older animals. We also observed a decreased 
pace of tolerance development to some of the aversive effects of nicotine 
in older animals. The behavioral differences could possibly be attributed 
to differences in acute nicotine effects on synaptic activity and excitatory 
transmission in nAc between young and old animals or to altered 
dopaminergic release in the older animals. 
Extended nicotine withdrawal influences GABAergic neurotransmission 
and GABA-related behaviors (paper III) 
The reinforcing and rewarding properties of nicotine have often been 
attributed to increased levels of DA in the nAc, through activation of 
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nAChRs in VTA. Stimulation of nAChRs will modulate the activity of 
projecting DA neurons and thereby also DA levels in selective striatal 
subregions, such as nAc (De Biasi and Dani, 2011). But the impact 
nicotine has on target neurons in nAc, i.e. mainly GABAergic neurons, 
and thereby GABAergic transmission and GABA release, is less well 
studied. Although, recent studies describe nicotinic influence on 
GABAergic transmission (Hernandez-Vazquez et al., 2014). Interestingly, 
nicotine can by stimulation of presynaptic nAChRs on GABAergic 
terminals directly influence GABA release (Hernandez-Vazquez et al., 
2014), and GABA can even be co-released with DA from dopaminergic 
terminals (Nelson et al., 2014). Thus when considering that GABAergic 
transmission causes tonic inhibition of dopaminergic transmission, it is 
plausible that nicotine can influence dopaminergic signaling through 
altered GABAergic transmission (Adermark et al., 2011). In addition, 
functional upregulation of nAChRs in mesolimbic pathways after nicotine 
exposure appears to be limited to midbrain GABAergic neurons (Nashmi 
et al., 2007; Xiao et al., 2009).  
Considering GABAergic involvement in nicotinic mechanism, we wanted 
to investigate how GABAergic transmission is altered during the course 
of extended nicotine withdrawal, ranging from acute exposure up to 
seven months of abstinence. We also investigated the role an altered 
GABAergic transmission may have on impulsive behavior, such as 
behavioral disinhibition, as an altered impulsive control could be involved 
in continued, or future, drug intake. 
Protracted nicotine abstinence affects behavioral disinhibition and produces gradual changes of ex 
vivo sensitivity to GABAA acting drugs 
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Figure 8. During the course of extended withdrawal the performance on the elevated 
plus-maze was altered in a temporal manner (A-D), and after two and three months of 
abstinence the nicotine treated animals displayed increased behavioral disinhibition (C-
D). Such temporal development was observed also with respect to the response of the 
GABAA receptor antagonist bicuculline, which was significantly depressed in nicotine 
treated animals after two and three months of withdrawal (G-H).  
Nicotine has been reported to employ a bimodal effect on anxiety-related 
behaviors (File et al., 1998), where lower doses are likely do produce an 
anxiolytic-like effect and higher doses have been reported to be 
anxiogenic (File et al., 1998; McGranahan et al., 2011; Ouagazzal et al., 
1999). In our hands nicotine abstinence induced an anxiolytic-like effect, 
or behavioral disinhibition, that developed during the course of extended 
withdrawal (Fig. 8A-D). This was detected as an increased open arm 
activity on the elevated plus-maze in previously nicotine treated animals. 
Interestingly, in the acute withdrawal phase the nicotine exposed animals 
showed a tendency to a decreased open arm activity (Fig. 8A), which over 
time progressively developed into the opposite (Fig. 8D). A gradual 
development was also observed with respect to the electrophysiological 
response to the GABAA antagonist bicuculline. Thus, the increased 
response observed in slices from nicotine treated animals in the acute 
withdrawal phase (Fig. 8E) was transposed into a decreased response two 
to three months later (Fig. 8H). This finding could suggest that GABAA 
ABSTINENCE 
ACUTE 3 MONTHS 
Ctrl Nicotine
0
10
20
30
40
50
%
 ti
m
e 
sp
en
t i
n 
op
en
 a
rm
Ctrl Nicotine
0
10
20
30
40
50
%
 ti
m
e 
sp
en
t i
n 
op
en
 a
rm
Ctrl Nicotine
0
10
20
30
40
50
%
 ti
m
e 
sp
en
t i
n 
op
en
 a
rm
Ctrl Nicotine
0
10
20
30
40
50
%
 ti
m
e 
sp
en
t i
n 
op
en
 a
rm
* *
A B C D 
E F G H 
0 10 20 30 40
0
20
40
60
80
100
120
140
160
Time(min)
PS
 a
m
pl
itu
de
 (%
 o
f b
as
el
in
e)
Vehicle (n = 14)
Nicotine (n = 17)
Bicuculline
0 10 20 30 40
0
20
40
60
80
100
120
140
160
Time (min)
Vehicle (n = 12)
Nicotine (n = 9)
Bicuculline
0 10 20 30 40
0
20
40
60
80
100
120
140
160
Time (min)
Vehicle (n = 10)
Nicotine (n = 9)
Bicuculline
0 10 20 30 40
0
20
40
60
80
100
120
140
160
Time (min)
Vehicle (n = 19)
Nicotine (n = 13)
Bicuculline
Nicotine sensitization and the effects of extended withdrawal 
28 
receptor function is increased in the acute abstinence phase and later 
decreased, possibly due to receptor subunit conversion or decreased gene 
expression. sIPSCs recordings revealed increased sIPSC amplitudes in the 
acute phase, as would suggest an enhanced postsynaptic GABAA 
response (see paper III, fig. 2). In fact, the amplitude was instead 
significantly reduced following three months of withdrawal, thus being in 
line with the lack of effect of bicuculline at this time point and suggesting 
that tonic inhibition in the system was reduced.  
Figure 9. The progressive effect to GABAA acting drugs was also observed with respect 
to the response of the agonist muscimol, where the difference increased over time (A-
C). Recordings revealed an inverted response to muscimol as compared to the response 
in controls, and after en extended withdrawal period of seven months the excitatory 
effect was largely increased in nicotine treated animals (C). 
The effect of the GABAA agonist muscimol was also evaluated during 
extended withdrawal, and as can be seen in figure 9 the expected 
decreased excitatory response was observed in slices from controls only. 
In slices from nicotine-treated animals, an increased excitation was 
detected instead and the response increased in size during the course of 
withdrawal (Fig. 9 A vs. C). Several possible mechanisms could underlie 
this rather unexpected finding, such as a switch in GABAA signaling 
properties, from inhibitory to excitatory, which has been described 
previously for VTA GABAA receptors after opiate exposure and brief 
opiate withdrawal (Laviolette et al., 2004; Vargas-Perez et al., 2009). 
0 10 20 30 40
0
20
40
60
80
100
120
140
Time (min)
Nicotine (n = 12)
Vehicle (n = 7)
Muscimol
0 10 20 30 40
0
20
40
60
80
100
120
140
Time (min)
Vehicle (n = 7)
Nicotine (n = 7)
Muscimol
0 10 20 30 40
0
20
40
60
80
100
120
140
Time (min)
PS
 a
m
pl
itu
de
 (%
 o
f b
as
el
in
e)
Vehicle (n = 12)
Nicotine (n = 10)
Muscimol
A 
7 months 
B C 
acute 3 months 
* ** ** 
Julia Morud Lekholm 
29 
Extended withdrawal induces progressive changes in accumbal neurotransmission together with 
altered spine density  
Figure 10. A progressive effect on synaptic efficacy was detected during the course of 
withdrawal and a significant depression was observed after three months of withdrawal 
in nicotine treated animals (D). An effect of time was noted also with respect to 
probability for transmitter release (F), as well as in spine density (H), where a significant 
effect was seen first after three months of withdrawal. 
To further evaluate if extended nicotine withdrawal would influence 
accumbal neurotransmission and synaptic function, we examined synaptic 
efficacy, transmitter release and spine density in nAc (Fig. 10). Again a 
delayed effect was observed with respect to synaptic efficacy, probability 
for transmitter release and spine density, where the effects were 
significantly altered first after an extended withdrawal period (Fig. 10D, 
F, H). Synaptic efficacy and probability for transmitter release were also 
depressed, whereas spine density was increased. This could suggest a 
compensatory synaptic effect in nAc due to an increased population of 
lowly functional synapses or AMPA receptor-silent synapses, which has 
previously been described after morphine and cocaine exposure 
(Graziane et al., 2016). Also, evoked inhibitory postsynaptic currents 
(eIPSCs) have been shown to be augmented in dorsal striatum during the 
acute abstinence phase, suggesting that a comparable process may occur 
in several subregions of the striatum (Miura et al., 2006). In addition, 
recent data indicates that nicotine induces rewiring of striatal circuits in a 
temporal manner, and these results could thus extend to involve the 
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recruitment of nAc later in the functional reorganization following that of 
dorsal parts (Adermark et al., 2016). 
In conclusion, we show that nicotine induces progressive changes in 
GABAergic neurotransmission, displayed as temporal-dependent 
alterations in the sensitivity to GABAA acting drugs as well as in 
spontaneous GABAergic neurotransmission. The temporal effect in 
accumbal neurotransmission is concomitant with the development of a 
spontaneous disinhibitory behavior. 
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GENERAL DISCUSSION 
The numerous effect of nicotine described in this thesis point to a 
complex pattern of neuronal alterations, which may or may not 
contribute to the severe addictive properties of the substance. Today only 
a few pharmacological options are available for reducing nicotine use, and 
these show limited efficacy and low rates of long-term cessation. When 
considering the ensuing increased risk for severe illness associated with 
long-term tobacco use, the need for improved therapies is significant. 
Thus, in order to increase the chances of developing new treatment it is 
of great importance to understand the processes and alterations 
underlying nicotine addiction. The purpose of this thesis was to 
investigate the impact of nicotine exposure and long-term nicotine 
abstinence on behavior and neuronal circuits in the reward system, as 
well as to determine how long-lasting these effects are. 
The possibility for the induction of chronic alterations after three weeks 
of nicotine exposure was assessed in paper I, in which we show that the 
effects of nicotine on locomotion were still present seven months after 
exposure. This was concomitant with an increased ex vivo response to a 
DA D2 receptor agonist in the nAc shell of nicotine-treated rats. These 
results are of particular importance for understanding the basic 
mechanisms of nicotine-induced behavioral sensitization and the neural 
alterations that contribute to the displayed behavior. Pre- and 
postsynaptic alterations of the DA system have for long been suggested 
to be involved in the sensitized response (Molander and Soderpalm, 
2003; Vezina, 1996), and here we show for the first time a significantly 
enhanced electrophysiological response to DA D2 receptor activation 
specifically in the nAc shell. 
We also show that nicotine induces chronic effects on the excitatory 
response in nAc, as measured by the input/output function, which could 
be due to a decreased glutamatergic drive or an increased inhibition from 
GABAergic transmission. Several parameters were also changed after 
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nicotine re-exposure, suggesting that the system has been reorganized to 
become highly receptive to the drug. A parallel can be made to 
observations in humans, where only a small amount of nicotine is 
sufficient to cause relapse (Brigham et al., 1990). Taken together, our 
results suggest that relatively modest exposure to nicotine (15 days) is 
enough to induce longstanding behavioral and neuronal effects that may 
have implications for the low probability of maintaining cessation, and 
that nicotine addiction probably should be considered a chronic state.  
The possible impact of age at first nicotine exposure was evaluated in 
paper II. We observed that young rats appeared to display a more rapid 
behavioral and neurophysiological response to nicotine exposure; this 
was manifested as faster behavioral sensitization as well as a more rapid 
tolerance development to the rearing depressing effects of nicotine. 
Moreover, we observed an age-dependent effect on synaptic activity, 
where only the youngest animals showed a depressant effect. But more 
importantly, the two older age groups did not differ at all in synaptic 
activity. This, together with the behavioral data, would suggest that the 
younger animals are more susceptible for nicotine, and one could 
speculate that neuronal changes are more easily established in young 
animals due to a highly plastic neuronal system with high synaptic density 
(Huttenlocher, 1979).  
We also investigated the response to nicotine in drug-naïve animals, both 
by examining accumbal DA release and excitatory output in field-
potential recordings. Both of these methods revealed an age-dependent 
response to nicotine, in which field potential recordings detected an 
increased effect of nicotine in slices from juvenile animals. The DA 
analysis also revealed an age effect; the aged animals displayed an 
elongated DA output after a systemic nicotine injection.  
Additionally, in paper III we describe progressive effects in GABAergic 
transmission, induced by extended nicotine withdrawal, in which e.g. 
sIPSCs amplitudes were significantly decreased after a three-month 
withdrawal period, while the response to a GABAA antagonist was 
blunted at the same time point. In addition, the response to the GABAA 
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agonist muscimol developed progressively during extended withdrawal, 
and after seven months the effect surprisingly switched to excitation, 
similar to what is known to happen after opiate exposure and brief opiate 
withdrawal (Laviolette et al., 2004). Interestingly, chronic exposure to 
drugs, and opiates in particular, has been reported to increase levels of 
brain-derived neurotrophic factor (BDNF) in VTA neurons, and local 
infusions with BDNF into VTA can alone influence the switch in 
GABAA signaling function (Vargas-Perez et al., 2009). Together this 
could suggest an important role for BDNF regulation in the development 
of the long-lasting and multifaceted drug-induced changes.  
Whether the GABAergic changes seen after seven months of abstinence 
are related to the enhanced response to the DA D2 receptor agonist 
observed in paper I, remains to be determined. In striatum quinpirole 
exerts its effects through presynaptic DA D2 autoreceptors on DA 
neuronal terminals, and through postsynaptic DA D2 receptors located 
on MSNs and cholinergic interneurons, but the electrophysiological 
effects observed in slices are most likely of a postsynaptic nature. Since it 
appears likely that GABAA receptors and DA D2 receptors interact on 
MSNs, one could thus suggest that aspects of the altered dopaminergic 
function after seven months of withdrawal could be due to a 
malfunctioning GABAergic inhibition.  
We also demonstrate that the behavior on the elevated plus-maze, which 
was used to assess behavioral disinhibition, is altered in a time-dependent 
manner in nicotine-treated animals, such that the activity on the open 
arms is increased after three months of abstinence. Increased open arm 
activity may be interpreted as an anxiolytic-like effect or as behavioral 
disinhibition. We further demonstrated that these types of behaviors 
possibly could be related to GABAergic transmission in nAc, since local 
injections with diazepam led to increased activity on the open arms. 
These findings add to recent evidence suggesting that nAc may be more 
important for anxiolytic or disinhibitory behaviors than previously 
thought (Feja et al., 2014). The induction of such a behavior could thus 
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be connected to nicotine-induced transformation of accumbal 
GABAergic transmission. 
Moreover, it seems as if the biphasic effect of GABAA-acting drugs over 
the course of withdrawal is reflected in gene expression of GABAA 
receptor subunits. This was assessed by qPCR, and several GABAA 
subunits, as well as the synaptic GABA transporter GAT-1, were 
downregulated in a parallel with development of a blunted response to 
GABAA acting drugs in nicotine treated animals. This could suggest that 
the blunted response to GABAA-acting drugs after three months of 
withdrawal is due to fewer or altered receptor targets.  
In conclusion, the results presented in this thesis describe longstanding 
effects from previous nicotine exposure, both on behavior and on 
neurotransmission in nAc, including GABAergic and dopaminergic 
systems. These changes are detectable up to seven months into 
withdrawal. Interestingly, several of the detected alterations appear first 
after an extended withdrawal period. These findings are relevant for the 
ongoing discussion regarding nicotine as a potential gateway drug, since 
the exposure to nicotine induces a cascade of neuronal events that 
together might increase the possibilities for future drug intake. The 
results also describe an age-dependent component in the nicotinic effects, 
where younger animals appear to be more susceptible to changes in 
accumbal transmission and develop behavioral adaptions to nicotine 
faster. Further knowledge of the nature of these alterations might 
increase the understanding of nicotine addiction, and thereby increase the 
chances of developing improved pharmacotherapies for this devastating 
disorder. 
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FUTURE PERSPECTIVES 
The pharmacological options to treat nicotine addiction are few and 
focused on substitution (nicotine replacement therapies; varenicline) or 
manipulation of the DA system (bupropion; varenicline). Given the 
limited effects of these treatments, there appears to be a significant need 
for looking at the disease from new angles. The results of the present 
thesis indicate a need for considering the role of altered accumbal 
neurotransmission in a broader sense, i.e. beyond DA, even though DA 
mechanisms cannot be disregarded. 
Development of a low functioning, or after seven months of abstinence 
possibly even reversed, GABAergic transmission in nAc raises the 
possibility that the GABAergic system should be considered as a 
potential drug target for nicotine dependence. One must however 
remember that these data derive from slice recordings, ex vivo. The status 
of GABAergic transmission in intact animals after seven months of 
nicotine abstinence remains to be determined, even though the results 
obtained in the elevated plus-maze after three months of abstinence are 
compatible with GABA-related behavioral changes. Further, we do not 
know if the observed GABAergic alterations are limited to nAc or if they 
extend to other brain regions. It is thus necessary to investigate additional 
regions, both in brain slice preparations and in vivo, before drawing 
conclusions as to how nicotine exposure and ensuing withdrawal alter 
GABAergic transmission. In addition, experiments capturing the 
behavioral features of addiction will be required to connect these changes 
to the phenomenon of nicotine addiction. Moreover, we do not know if 
intracellular chloride concentrations are altered, for example due to 
malfunctioning or reversed function of the GABAA receptors, or if the 
amount of GABA in the extracellular space is augmented. These 
questions remain to be investigated. 
Recently published data from the group also describes nicotine-induced 
rewiring of striatal subregions (Adermark et al., 2016), a dynamic process 
that in the acute phase involves changes in synaptic activity in DMS and 
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in later stages in DLS and nAc. At the later time points, the changes 
earlier detected in DMS are completely abolished and normalized to that 
of controls. Whether or not the changes in accumbal synaptic activity are 
propagated to other brain regions connected to the striatum is not 
known. The nicotine-induced effect in DLS has also been shown to 
disappear after six months of withdrawal (Adermark et al., 2016), at a 
time point where it is still present in the nAc. If and when nicotine-
induced alterations disappear at a later time point in nAc is not known. 
The vast majority of studies looking at nicotine-induced effects, both in 
terms of behaviors and neurotransmission, utilizes short time periods - 
both for treatment and in particular for the succeeding abstinence period. 
Due to this, important aspects of nicotine addiction may have been 
overlooked, and extended withdrawal should be considered to a greater 
extent.  
Historically, mechanistic studies of nicotine have focused intensely on the 
VTA, due to the fact that nAChRs are dense on DA neurons in VTA. In 
contrast, the interest for striatal regions, apart from DA release, has been 
limited. When looking only at DA release and/or DA receptor function 
in striatal regions, important consequences of nicotine exposure, such as 
the induction of silent synapses or the role of BDNF regulation may be 
missed. It is thus of interest to continue investigating how nicotine alters 
local accumbal transmission using a more multifaceted approach, and to 
determine if the observed changes can be prevented, inhibited or 
reversed by pharmacological pretreatments or treatments. 
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APPENDIX: MATERIALS AND METHODS 
Below follows a brief introduction and reflections on practical as well as theoretical 
aspects to the different experimental methodologies used in papers comprising this 
thesis.  
Animals 
During the last century, the use of animal models has contributed 
enormously to the progress in understanding physiological principles. 
This thesis is based on experiments performed in Wistar rats, a 
commonly used animal model for studying addiction and 
neurotransmission. The translation between humans and rats is possible 
due to the fact that several key brain regions are conserved and there is 
an approximate genomic overlap of 95%. The validity of each animal 
model used is briefly discussed in each subchapter below. All experiments 
presented in this thesis were approved by the Ethics Committee for 
Animal Experiments, Gothenburg, Sweden. 
In the nicotine sensitization studies (papers I and III) outbred adult 
Wistar rats were used, weighing 240-280 g at the start of the experiment 
(Taconic, Ejby, Denmark). All animals were housed in groups of three. In 
the age-contingent nicotine study (Paper II) Wistar rats of three different 
ages were used, 4, 9 or 35 weeks old (Taconic, Ejby, Sweden).  All 
animals were housed at room temperature 21-22°C and with a 12-h 
light/dark cycle and had free access to rat chow (Lantmännen, Sweden) 
and tap water.  
Drugs and Chemicals 
Nicotine was dissolved in 0.9% NaCl and the pH was adjusted to 7.2-7.4 
with NaHCO3. The animals were given 0.36 mg/kg s.c. (active substance) 
daily for three weeks. The benzodiazepine diazepam was dissolved in a 
sham solution consisting of: 10% 95%-ethanol, 40% propylene glycol, 
50% Ringer’s solution and injected bilaterally into the nAc, 20 µg in total. 
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Ringer’s solution contained (in mM): 140 NaCl, 1.2 CaCl2, 3.0 KCl, and 
1.0 MgCl2. For electrophysiological experiments, nicotine (1 µM), and the 
D2/D3 agonist quinpirole (5 µM) were dissolved in artificial cerebrospinal 
fluid (aCSF), which consisted of (in mM); 194 sucrose, 30 NaCl, 4.5 KCl, 
1 MgCl2, 26 NaHCO3, 1.2 NaH2PO4, 10 d-glucose. The GABAA 
antagonist bicuculline was dissolved in DMSO and diluted to 20 µM in 
aCSF and the GABAA agonist muscimol was dissolved in H2O to 50 mM 
and diluted in aCSF to 1 µM. The cutting solution for brain slice 
preparation contained (in mM): 194 sucrose, 30 NaCl, 4.5 KCl, 1 MgCl2, 
26 NaHCO3, 1.2 NaH2PO4, 10 D-glucose. For whole-cell patch clamp 
purposes the aCSF constituted of: (in mM) 1.25 NaH2PO4, 124 NaCl, 26 
NaHCO3, 3 KCl, 2 MgCl2, 2 CaCl2 and 10 D-glucose and the pipette 
solution contained (in mM): 130 Cs-methanesulfonate, 2 NaCl, 10 
HEPES, 0.6 EGTA, 5 Qx-314, 4 Mg-ATP and 0.4 GTP (pH 7.3, 
adjusted with D-gluconic acid). 
Behavior 
The studies of animal behavior that are included in this thesis all utilize 
ethological behavioral principles, as opposed to operant, in manners of 
investigating naturalistic influences of nicotine.  
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Figure 11. Descriptive figures of the equipment used for behavioral assays described 
below. 
Locomotor measurements 
The animals were injected daily with nicotine (0.36 mg/kg, s.c.) to induce 
behavioral sensitization, a phenomenon when the same dose of drug 
induces a heightened drug response after repeated exposure (Benwell and 
Balfour, 1992). The stimulatory effect of the drug was assessed by 
measuring locomotor activity in an open-field arena (Fig. 11), once 
weekly during the three weeks drug administration period. The open-field 
arena was equipped with infrared beam detectors in two layers, which are 
triggered once the animal disrupts any beam allowing movement patterns 
to be traced in three dimensions (x, z and y-axis). The rats were allowed 
to habituate for 30 minutes in the test boxes (paper I and II: box 
diameter 70 x 70 cm, Kungsbacka Mät- och reglerteknik AB, 
Kungsbacka, Sweden, paper III: 40 x 40 cm, Med Assoc, Fairfax, VT, 
USA), in order to separate the drug effect from initial exploration of the 
novel environment. After habituation the animals were injected with 
nicotine or 0.9% NaCl and the registration of locomotion continued after 
a five minutes pause in order to avoid influence of injection-induced 
hypermotility. Testing continued for a total of 35 minutes after injection 
and total ambulatory movement, rearing activity and the time spent in 
corners were recorded throughout the test. 
Measures of behavioral disinhibition 
To evaluate behavioral disinhibition, the elevated plus-maze (EPM) test 
was used (Fig. 11). This test exploits the conflict between the urge to 
explore a novel environment and the simultaneous natural tendency for 
rodents to avoid open, elevated and bright spaces (Walf and Frye, 2007). 
Normally the exploration of the open spaces is suppressed or inhibited. 
Entering into the open spaces thus represents a disinhibited behavior, 
which in turn could be due to a number of alterations of the animal’s 
internal state, e.g. anxiolysis or increased impulsivity or perhaps even 
confusion.  
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The apparatus consisted of black plastic with two closed arms and two 
open arms measuring 10 x 50 x 1 or 40 cm (Med Associates, St Albans, 
VT, USA). The maze was elevated 1 m above the floor and the animals 
were habituated to the testing room during 30 minutes before testing. 
Before placement on the maze the animals were placed in an unfamiliar 
open-field arena for 5 minutes, in order to stimulate explorative behavior. 
Each animal was assessed during 5 minutes on the maze, the time spent 
in each arm and number of entries made into each arm was recorded. 
Local accumbal injections 
For paper III, drug naïve animals (n=34), weighing 280-330 g, were 
injected with a GABAergic agonist diazepam (20 µg) into nAc (Chau et 
al., 2010), before testing on the elevated plus maze. Briefly, accumbal 
injections were given via implanted guide cannula (Plastics One Inc, 
Roanoke, VA, USA), which was positioned bilaterally during isoflurane 
anesthesia (Baxter, Apoteket AB, Stockholm, Sweden) into the nAc 
(AP:+1.7, ML:±1.4, DV: -6.0) one week before experiments. The guide 
cannula was fixated to the skull using acrylic cement (Dentalon, 
AgnThos, Sweden). Each animal was injected with a total volume of 1 
µl/hemisphere (perfusion rate 0.5 µl/min) of either active substance or 
control solution. 
Methodological considerations 
Automatic locomotor recording are commonly used for the study of 
drug-induced stimulatory responses. The initial arena size used in papers I 
and II was slightly larger than the one in paper III. This larger arena can 
be utilized for open-field testing, making the measurements of time spent 
in corners or the center more accurate, as compared to the case in the 
smaller arena. Therefore, no such measurements were included in paper 
III. This is somewhat unfortunate as such measurements could have been 
a good complement to the EPM test. The drug-induced increase of 
locomotion measured in the two types of arenas should however be 
comparable, since the drug effect is so prominent that the deviation in 
size between the two different arenas most likely can be overlooked.  
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The EPM relies on rodents’ tendency to prefer dark and enclosed spaces 
and to fear bright and open spaces (Walf and Frye, 2007). Impulsive 
behaviors can be subdivided into different behaviors, such as impulsive 
choice or behavioral disinhibition; both types of behaviors involve the 
inability to constrain an unplanned action. Several operant or ethological 
assays used in order to measure impulsive behaviors uses 
noxious/negative stimuli (e.g. electric shock, odor presentation), which 
often produce a conditioned response.  The valence of both a positive 
and negative conditioned stimuli can thus be avoided using the simple 
model of EPM. This model utilizes spontaneous exploration of two 
different types of environments, of which one is being a bit more 
frightening for the rat. Although, the EPM is in fact most commonly 
used for studying anxiety-like behaviors, since it has high face and 
construct validity for anxiety due to the induction of anxiolytic-like 
effects after administration of benzodiazepines or 5-HT1A agonists, which 
causes anxiolysis in humans. These substances will increase the 
propensity of animals entering into open arms and spending more time in 
the open arms (Soderpalm and Engel, 1990), and this is then interpreted 
as a sign of anxiolysis. However, in the present thesis and in paper III we 
have avoided to interpret the outcome in EPM in terms of anxiety or 
anxiolysis and instead used the operational term “behavioral 
disinhibition”, since this is what is observed. A disinhibited, impulsive 
animal may very well enter the aversive, open arm in spite of being 
anxious. Thus, as mentioned previously, entering into the open arms of 
the EPM could be due to increased impulsivity and/or anxiolysis, and/or 
spatial confusion.  
In paper III animals were injected with diazepam locally in nAc before 
testing of disinhibitory behavior. The placement of the injection needle 
was examined after the experiments in brain slices from these animals, 
but this is still a rough estimation of the exact area that was affected by 
the drug. One needs to account for the drug perfusion rate in the tissue 
and how far the drug might spread before testing. As diazepam is a 
lipophilic substance, the expected spread in the tissue is rather high. To 
minimize this regional bias, we only allowed the drug to incubate for five 
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minutes before starting the test. But we have not done region-specific 
controls to completely assure that no other region was affected that 
might also be involved in the disinhibitory behavior observed after 
diazepam injection. 
In vivo Microdialysis 
In vivo brain microdialysis allows measurement of extracellular substances, 
such as neurotransmitters, in awake and freely moving animals. The 
technique also enables the administration of substances locally to the 
surrounding area of the implanted microdialysis probe, so-called reversed 
dialysis (Fig. 12). In study II this technique was used to measure 
extracellular levels of DA.  
Figure 12. Graphical 
description of the principle 
behind in vivo microdialysis, in 
which a semi-permeable 
membrane allows molecules 
from the extracellular space to 
diffuse over and into the 
probe from which the fluid is 
then sampled and analyzed by 
HPLC. The membrane also 
allows for molecules to diffuse 
out from the probe and into 
the extracellular space, 
enabling local pharmacological 
treatment. 
 
Microdialysis technique 
Two days before running the microdialysis experiment animals were 
unilaterally implanted with a custom-made I-shaped microdialysis probe, 
equipped with a semi-permeable dialysis membrane, in to the nAc (AP: 
+1.65 mm, ML: -1.4 mm relative to bregma, DV: -7.8 mm relative to 
dura) (Paxinos G, 2007) as described previously in (Morud et al., 2015). 
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The zone availed for passive diffusion on the probe, often referred to as 
the active space, was 2 mm Briefly, rats were anesthetized using 
isoflurane and mounted into a stereotaxic instrument (David Kopf 
Instruments, AngTho’s, Lidingö, Sweden), animals were locally injected 
with Marcain® (buvipacaine, AstraZeneca, Sweden) for a local anesthetic 
effect around the incision. The animals were kept on a heating pad 
throughout the surgery. Two holes for anchoring screws were drilled, and 
one for insertion of the probe. The probe and the anchoring screws were 
fixated to the scull using Harvard cement (DAB Dental AB, Gothenburg, 
Sweden). After the surgery all rats received a 0.9% saline injection to 
prevent dehydration. On day of experiments probes were connected to a 
microperfusion pump (U-864 Syringe Pump, AgnTho’s, Lidingö, 
Sweden), via a swivel. Probes were then perfused with Ringer solution for 
two hours before the sampling started in order to obtain a balanced fluid 
exchange, samples were then taken every 20th minute following this. 
Animals were sacrificed immediately after the experiment and the brains 
were removed and fixated for later probe placement conformation.  
Neurochemical assay 
High performance liquid chromatography (HPLC), (ThermoScientific, 
Waltham, MA, USA), with electrochemical detection (system 1: 400 mV 
system 2: 220 mV, versus the cell) was used for detection of DA in the 
dialysate. Two systems were used in parallel, system one was equipped 
with a 2x150 mm ion exchange column (Nucleosil SA, 5 µM, pore size 
100 Å, Phenomenex, Sweden) and the mobile phase consisted of in mM: 
135 NaOH, 58 citric acid, 0.107 Na-EDTA, 20% methanol. System two 
utilized a 2x50 mm reversed phase column (silica, 3 µm diameter, pore 
size 100 Å, Phenomenex, Sweden) and the mobile phase consisted of in 
mM: 150 NaH2PO4, 4.76 citric acid, 3 SDS, 50 µM EDTA, 10 % 
methanol, 15% acetonitrile. For identification of DA peaks and 
calculation of DA concentrations, an external DA standard was used 
(3.25 fmol/µl). Before introducing the drug to be tested, four stable 
baseline samples were analyzed from each animal (internal difference 
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more than ±10% was not accepted). The following samples were treated 
as percentage of baseline.  
Methodological considerations 
In the experimental setting used in our group for sampling brain micro 
dialysates, the sampling rate is often set to every 20th minute. The low 
sampling rate is necessary for the collection of sufficient amounts of 
fluid needed for the HPLC analysis, which has implications for missing 
real-time changes in dopaminergic transmission that takes place on a 
millisecond level. Due to this, in vivo microdialysis is mostly suitable for 
monitoring slower processes such as effects after chronic systemic 
treatments or aggravated effects on transmission. Thus, it is a powerful 
tool for studying neural circuits since the use of multiple microdialysis 
probes enables one brain area to be manipulated in vivo at the same time 
as another is monitored for changes in transmission. Also, the type of 
microdialysis technique used in paper II does not measure absolute 
concentrations of extracellular DA and these measurements should then 
rather be considered to reflect changes in volume transmission.  
Another challenge with in vivo microdialysis is how to dose your 
substances for local perfusion through the probe. Both due to the fact 
that most literature on these substances reflects systemic administration 
or for use ex vivo, on slice preparations that use a different range of 
concentrations and doses. But most importantly, due to the features of 
the semi-permeable membrane at the tip of the probe it is hard to 
estimate how large the fraction is that will enter into the extracellular 
space. The membrane has an average molecular cut-off at 20 kDa, but 
this can likely vary due to intrinsic properties of substances e.g. the 
polarity of the drug and shape, but also factors such as perfusion rate and 
temperature. Altogether, there are several difficulties to be met when it 
comes to estimating the amount of active substance that will be available 
in the tissue, and therefore we often estimate an excovery rate of 10-
20%, which means that the actual in situ concentration might both be 
higher and lower than anticipated and therefore is the perfusate 
concentration always stated in the method and not the actual dialysate 
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concentration. Additionally, the impact made by the microdialysis probe 
in the surrounding tissue needs to be accounted for. The probe is 
implanted two days prior sampling and during these days a substantial 
amount of gliosis has occurred around the probe (Norton et al., 1992) 
and the surrounding tissue might also have been obstructed by blood or 
mechanical damaged from the surgery. 
Electrophysiology 
Electrophysiological studies in acutely prepared brain slices are well-
established experimental models for studying electrical activity and 
cellular mechanisms. In paper I, II and III field-potential recordings were 
performed and in paper III whole-cell patch clamp was also utilized.  
Brain slice preparations 
Animals were deeply anesthetized with isoflurane (Forene®, Baxter, 
Sweden) before decapitation. The brains were then quickly removed and 
placed in cold cutting solution. After five minutes of incubation the 
brains were cut coronally on a vibratome (Zeiss, Jena, Germany) in 400 
µm thick slices, including the striatal nucleus and the overlaying cortex. 
Brain slices were then allowed to equilibrate for at least 1 h at room 
temperature in regular aCSF solution bubbled with a mixture of 95% 
O2/5% CO2 gas before transferred to the recording chamber. 
Field potential recordings 
In brief, synaptic efficacy was estimated by measuring the amplitude of 
the population spike (PS). Stimulation was yield through a tungsten 
electrode, which delivered pulses every 20s and placed in the nAc shell or 
core (paper I) or only shell (paper II, III). The stimulus intensity was set 
to yield a PS amplitude approximately half the size of the maximal 
evoked response. After monitoring a stable baseline for 10 min slices 
were treated with either quinpirole (5 µM) or nicotine (1 µM) (paper I, 
II), or muscimol (1 µM) and bicuculline (20 µM) (paper III). In a subset 
of recordings differences in input-output function were evaluated by 
stepwise increasing afferent stimulation strength. Changes in release 
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probability were also estimated by calculating the amplitude ratio (second 
pulse/first pulse) between two paired pulses, PPR, delivered with a 50 
ms interpulse interval. 
Whole-cell patch clamp 
In paper III medium spiny neurons of nAc were investigated using 
whole-cell patch clamp, in which the spontaneous excitatory or inhibitory 
postsynaptic currents (sEPSC or sIPSC) of the cell can be measured.  
During the experiment the brain slices were continuously perfused with 
aCSF (2–3 ml/min) and all recordings were performed at 30°C. The 
neurons were visually identified with an infrared differential interference 
contrast video microscopy mounted on a Nikon E600FN microscope. 
Whole-cell patch clamp recordings were performed with a patch clamp 
amplifier (EPC-9, Heka Elektronik, Lambrecht, Germany), the sampling 
frequency was 10 kHz and filtered at 2.9 kHz. For recording of sEPSCs 
the neurons were voltage clamped at -70 mV and at 0 mV to record 
sIPSCs. Patch pipettes (borosilicate, OD 1.5 mm, ID 0.86 mm) had a 
resistance of 3.0–6.5 MΩ. Series resistance was monitored using a 10 mV 
hyperpolarizing pulse and there were no differences in the average series 
resistance between the different groups. 
Methodological considerations 
Measuring neuronal signaling by estimation of electrical activity is a 
common method in neuroscience and it was first initiated in the early 
1970’s in hippocampal brain slices (Skrede and Westgaard, 1971). Due to 
several reasons, such as the lamellar organization, electrophysiological 
protocols used in hippocampus has been the major experimental model 
for both field-potential recordings and whole-cell patch clamp recordings. 
When utilizing this technique in striatal slices some aspects needs to be 
considered, such as the complexity in striatal cytoarchitecture where the 
dendritic arbors are not separated between subregions and the dendrites 
of the striatal MSNs are not uniformly oriented. Therefore we report the 
size of the amplitude population spike over slope of the EPSP (field 
excitatory post-synaptic potential), since this reflects the efficacy of 
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excitatory synaptic input through synchronous synaptically driven action 
potentials.  
When preparing the brain slices parts of the neuronal input is lost, since 
the tissue is cut and several afferent and efferent connections are lost. 
And as such the recordings only reflect local outcomes and cannot 
directly be translated into the functions of an intact brain. The field 
recordings are preferable over patch clamp recording in some matters, 
such as keeping the intracellular composition of the cells intact, since the 
patch clamp technique requires that the neuronal membrane to rupture. 
However, this is also the strength of the patch clamp technique since you 
get a direct contact with the cell interior, which allows for recordings of 
electrical currents and potentials. In addition, the cutting procedure itself 
might cause severe tissue damage and cell death in the outer layers of the 
slice, with implications for cellular function and immunological 
responses. 
Histochemistry 
Slices from nicotine treated or vehicle treated rats were stained using the 
Golgi staining. This method is based on the formation of silver chromate 
microcrystals within neurons, which make a random number of neurons 
visual enabling the study of fine neural structures such as dendritic spines.  
Rats were perfused with Ringer’s solution and cold 4% para-
formaldehyde. Brains were removed and post fixated for 90 minutes in 
room temperature, they were then impregnated in a Golgi-Cox fast kit 
(FD NeuroTechnologies Inc, Columbia MD, USA) for a total of three 
weeks (solutions were changed three times) and the brains were cut at 60 
µm using a microtome (Zeiss, Jena, Germany) and stained accordingly to 
the company protocol. A Zeiss lsm 700 inverted confocal microscope 
(Zeiss, Jena, Germany), or an Olympus BX60 (Olympus Corp. PA, USA) 
was used to identify the dendrites of medium spiny neurons within the 
nAc. A 63x oil objective (NA 1.4) with 1.7 digital zoom was used on the 
Zeiss microscope and a 100x oil objective (NA 1.3) with cellSens image 
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analysis software was used to capture images on the Olympus setup. A 
subset of images of dendritic segments was done using the Z-stack 
function with 0.25 µm steps, these images were used as descriptive 
micrographs of in paper I. Spine inclusion criterions for dendrites were: 
the extend of the dendritic tree had to be well stained and visible, not 
obscured by blood vessels, astrocytes or other cells as described by Li and 
co-workers (Li et al., 2003). 
Methodological considerations 
Why only a small fraction of all cells are stained with the silver chromate 
microcrystals is still largely unknown. This is very beneficial in matters of 
visibility, since it allows for a clear background with only one intact cell in 
focus. This creates a clear tissue, which makes the possibility of using 
thicker sections (60-80 µm) doable, enabling the study of the entire 
dendritic tree. Therefore we chose to measure spine density starting at the 
third branch of the dendritic tree and all the way out to the tip of the 
dendrite. The shortcoming of not knowing the mechanism behind the 
staining selection is the risk of measuring spine density in what could be a 
few percentages of cells that deviate in some manners, and it might thus 
not represent the true cellular population. 
Gene expression 
Gene expression analysis is a common method for gaining insight in the 
regulation of genes, as this could have implications for receptor function. 
In paper III the gene expression of selected GABAA subunits and the 
GABA transporter GAT-1 were measured using the technique 
quantitative polymerase chain reaction (qPCR). The method is based on 
the possibility to amplify a specific fragment of DNA using multiple 
temperature cycles, this results in such high quantities of DNA so as it 
can be reliably measured.  
Tissue from nAc was snap frozen after dissection and later homogenized 
using a phenol and guanidine thiocyanate (QIAzol Lysis Reagent, Qiagen, 
Hilden, Germany) solution. RNA was extracted using the Lipid Tissue 
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mini Kit from Qiagen. RNA concentrations were measured in a 
Nanodrop 2000 (Thermo Fisher Scientific, Wilmington, DE, USA) and a 
total of 800 ng of RNA was converted to cDNA using the QuantiTect 
Reversed Transcription Kit (Qiagen). The expression of target genes 
(Gabra1, Gabra2, Gabrb2, Gabrd2, Gabrg2 and SLC6A1) was normalized 
against three reference genes (RPL-1, RPL-19 and HPRT, all primers 
from Qiagen, QuantiTect Primer assay). qPCR reactions were performed 
using the QuantiFast SYBR Green Master Mix (Qiagen) in a LightCycler® 
480 PCR System (Roche Applied Science, Indianapolis, IN, USA). The 
data was analyzed in LightCycler® 480 software (version 1.5). 
Methodological considerations 
The accuracy of PCR is largely dependent on the primer specificity, for 
the PCR experiments performed in paper III pre-designed primers were 
used. Although this means that the company supplies you with an 
approximate location and guarantees a high specificity, but this was in 
fact never tested from our end. And since the company keeps the exact 
sequence a secret we cannot control for this. One also needs to keep in 
mind that the measure of gene expression is not a direct correlate to 
protein (e.g. receptor) function, since the receptor can be unavailable due 
to an inactive state or rapid internalization even though highly expressed. 
Statistical analysis 
All data was tested for Gaussian distribution with the D’Agostino-
Pearson omnibus normality test, before being assign a specific statistical 
test, which resulted in either a parametric Student’s t-test or a 
nonparametric Mann-Whitney U test. Group and treatment effects were 
tested using a one or two-way ANOVA (for microdialysis data with 
repeated measures) and a Sidak’s test for multiple comparisons.  Field 
potential recordings were analyzed with Clampex 10.1 (Molecular 
Devices, Foster City, CA) and whole-cell patch clamp data with Mini 
Analysis Program (version 5.6.28, Synaptosoft Inc., Fort Lee, NJ, USA). 
All other analysis was done in GraphPad Prism 6 (GraphPad Software, 
Inc., San Diego, CA, USA). 
Julia Morud Lekholm 
 
53 
REFERENCES 
Adermark L, Clarke RB, Ericson M, Soderpalm B (2011) Subregion-Specific 
Modulation of Excitatory Input and Dopaminergic Output in the Striatum by 
Tonically Activated Glycine and GABA(A) Receptors. Frontiers in systems 
neuroscience 5:85. 
Adermark L, Morud J, Lotfi A, Danielsson K, Ulenius L, Soderpalm B, 
Ericson M (2016) Temporal Rewiring of Striatal Circuits Initiated by 
Nicotine. Neuropsychopharmacology : official publication of the American 
College of Neuropsychopharmacology. 
Adriani W, Spijker S, Deroche-Gamonet V, Laviola G, Le Moal M, Smit AB, 
Piazza PV (2003) Evidence for enhanced neurobehavioral vulnerability to 
nicotine during periadolescence in rats. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 23:4712-4716. 
Albuquerque EX, Pereira EF, Alkondon M, Rogers SW (2009) Mammalian 
nicotinic acetylcholine receptors: from structure to function. Physiological 
reviews 89:73-120. 
Alheid GF, Heimer L (1988) New perspectives in basal forebrain 
organization of special relevance for neuropsychiatric disorders: the 
striatopallidal, amygdaloid, and corticopetal components of substantia 
innominata. Neuroscience 27:1-39. 
Arbuthnott GW, Wickens J (2007) Space, time and dopamine. Trends in 
neurosciences 30:62-69. 
Benowitz NL, Porchet H, Jacob P (1990) Pharmacokinetics, metabolism, and 
pharmacodynamics of nicotine. Oxford: Oxford University Press. pp 112-
157. 
Benwell ME, Balfour DJ (1992) The effects of acute and repeated nicotine 
treatment on nucleus accumbens dopamine and locomotor activity. British 
journal of pharmacology 105:849-856. 
Nicotine sensitization and the effects of extended withdrawal 
54 
Berridge KC (2012) From prediction error to incentive salience: mesolimbic 
computation of reward motivation. The European journal of neuroscience 
35:1124-1143. 
Bertrand D, Galzi JL, Devillers-Thiery A, Bertrand S, Changeux JP (1993) 
Mutations at two distinct sites within the channel domain M2 alter calcium 
permeability of neuronal alpha 7 nicotinic receptor. Proceedings of the 
National Academy of Sciences of the United States of America 90:6971-
6975. 
Breslau N, Peterson EL (1996) Smoking cessation in young adults: Age at 
initiation of cigarette smoking and other suspected influences. Am J Public 
Health 86:214-220. 
Brickley SG, Mody I (2012) Extrasynaptic GABA(A) Receptors: Their 
Function in the CNS and Implications for Disease. Neuron 73:23-34. 
Brigham J, Henningfield JE, Stitzer ML (1990) Smoking relapse: a review. 
The International journal of the addictions 25:1239-1255. 
Brody AL, Mandelkern MA, London ED, Olmstead RE, Farahi J, Scheibal 
D, Jou J, Allen V, Tiongson E, Chefer SI, Koren AO, Mukhin AG (2006) 
Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine 
receptors. Archives of general psychiatry 63:907-915. 
Cadoni C, Di Chiara G (2000) Differential changes in accumbens shell and 
core dopamine in behavioral sensitization to nicotine. European journal of 
pharmacology 387:R23-25. 
Carlsson A, Falck B, Fuxe K, Hillarp NA (1964) Cellular Localization of 
Monoamines in the Spinal Cord. Acta Physiol Scand 60:112-119. 
Carlsson A, Lindqvist M, Magnusson T, Waldeck B (1958) On the presence 
of 3-hydroxytyramine in brain. Science 127:471. 
Caulfield MP, Higgins GA (1983) Mediation of nicotine-induced convulsions 
by central nicotinic receptors of the 'C6' type. Neuropharmacology 22:347-
351. 
Julia Morud Lekholm 
 
55 
Chagraoui A, Skiba M, Thuillez C, Thibaut F (2016) To what extent is it 
possible to dissociate the anxiolytic and sedative/hypnotic properties of 
GABAA receptors modulators? Progress in neuro-psychopharmacology & 
biological psychiatry 71:189-202. 
Chau P, Hoifodt-Lido H, Lof E, Soderpalm B, Ericson M (2010) Glycine 
receptors in the nucleus accumbens involved in the ethanol intake-reducing 
effect of acamprosate. Alcoholism, clinical and experimental research 34:39-
45. 
Christensen MH, Ishibashi M, Nielsen ML, Leonard CS, Kohlmeier KA 
(2014) Age-related changes in nicotine response of cholinergic and non-
cholinergic laterodorsal tegmental neurons: Implications for the heightened 
adolescent susceptibility to nicotine addiction. Neuropharmacology 85:263-
283. 
Clarke PB (1990) Dopaminergic mechanisms in the locomotor stimulant 
effects of nicotine. Biochemical pharmacology 40:1427-1432. 
Clarke PB, Fu DS, Jakubovic A, Fibiger HC (1988) Evidence that 
mesolimbic dopaminergic activation underlies the locomotor stimulant action 
of nicotine in rats. The Journal of pharmacology and experimental 
therapeutics 246:701-708. 
Clarke PB, Hamill GS, Nadi NS, Jacobowitz DM, Pert A (1986) 3H-nicotine- 
and 125I-alpha-bungarotoxin-labeled nicotinic receptors in the 
interpeduncular nucleus of rats. II. Effects of habenular deafferentation. The 
Journal of comparative neurology 251:407-413. 
Clarke PB, Kumar R (1983a) The effects of nicotine on locomotor activity in 
non-tolerant and tolerant rats. British journal of pharmacology 78:329-337. 
Clarke PB, Pert A (1985) Autoradiographic evidence for nicotine receptors 
on nigrostriatal and mesolimbic dopaminergic neurons. Brain research 
348:355-358. 
Clarke PB, Pert CB, Pert A (1984) Autoradiographic distribution of nicotine 
receptors in rat brain. Brain research 323:390-395. 
Nicotine sensitization and the effects of extended withdrawal 
56 
Clarke PB, Schwartz RD, Paul SM, Pert CB, Pert A (1985) Nicotinic binding 
in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, 
and [125I]-alpha-bungarotoxin. The Journal of neuroscience : the official 
journal of the Society for Neuroscience 5:1307-1315. 
Clarke PBS, Kumar R (1983b) The Effects of Nicotine on Locomotor-
Activity in Non-Tolerant and Tolerant Rats. British journal of pharmacology 
78:329-337. 
Corbit LH, Muir JL, Balleine BW (2001) The role of the nucleus accumbens 
in instrumental conditioning: Evidence of a functional dissociation between 
accumbens core and shell. The Journal of neuroscience : the official journal 
of the Society for Neuroscience 21:3251-3260. 
Corrigall WA, Coen KM (1991) Selective dopamine antagonists reduce 
nicotine self-administration. Psychopharmacology 104:171-176. 
Corrigall WA, Franklin KB, Coen KM, Clarke PB (1992) The mesolimbic 
dopaminergic system is implicated in the reinforcing effects of nicotine. 
Psychopharmacology 107:285-289. 
Dahlstrom A, Fuxe K (1964) Localization of monoamines in the lower brain 
stem. Experientia 20:398-399. 
Dani JA (2001) Overview of nicotinic receptors and their roles in the central 
nervous system. Biological psychiatry 49:166-174. 
Dani JA (2015) Neuronal Nicotinic Acetylcholine Receptor Structure and 
Function and Response to Nicotine. Int Rev Neurobiol 124:3-19. 
De Biasi M, Dani JA (2011) Reward, addiction, withdrawal to nicotine. Annu 
Rev Neurosci 34:105-130. 
Di Chiara G (2000) Role of dopamine in the behavioural actions of nicotine 
related to addiction. European journal of pharmacology 393:295-314. 
Di Chiara G, Bassareo V (2007) Reward system and addiction: what 
dopamine does and doesn't do. Curr Opin Pharmacol 7:69-76. 
Julia Morud Lekholm 
 
57 
DiFranza JR, Rigotti NA, McNeill AD, Ockene JK, Savageau JA, St Cyr D, 
Coleman M (2000) Initial symptoms of nicotine dependence in adolescents. 
Tob Control 9:313-319. 
Dworkin S, Guerin G, Co C, Smith J, Goeders N (1988) Effects of 5,7-
dihydroxytryptamine lesions of the nucleus accumbens in rats responding on 
a concurrent schedule of food, water and intravenous morphine self-
administration. NIDA Res Monogr 81:149-155. 
Ericson M, Olausson P, Engel JA, Soderpalm B (2000) Nicotine induces 
disinhibitory behavior in the rat after subchronic peripheral nicotinic 
acetylcholine receptor blockade. European journal of pharmacology 397:103-
111. 
Everitt BJ (1990) Sexual motivation: a neural and behavioural analysis of the 
mechanisms underlying appetitive and copulatory responses of male rats. 
Neurosci Biobehav Rev 14:217-232. 
Feja M, Hayn L, Koch M (2014) Nucleus accumbens core and shell 
inactivation differentially affects impulsive behaviours in rats. Progress in 
neuro-psychopharmacology & biological psychiatry 54:31-42. 
Fenster CP, Whitworth TL, Sheffield EB, Quick MW, Lester RA (1999) 
Upregulation of surface alpha4beta2 nicotinic receptors is initiated by 
receptor desensitization after chronic exposure to nicotine. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 19:4804-
4814. 
Fields S, Collins C, Leraas K, Reynolds B (2009) Dimensions of impulsive 
behavior in adolescent smokers and nonsmokers. Exp Clin Psychopharmacol 
17:302-311. 
File SE, Kenny PJ, Ouagazzal AM (1998) Bimodal modulation by nicotine of 
anxiety in the social interaction test: role of the dorsal hippocampus. 
Behavioral neuroscience 112:1423-1429. 
Fillmore MT, Rush CR, Hays L (2002) Acute effects of oral cocaine on 
inhibitory control of behavior in humans. Drug Alcohol Depend 67:157-167. 
Fletcher HG (1941) The history of nicotine. J Chem Educ 18:303. 
Nicotine sensitization and the effects of extended withdrawal 
58 
Floresco SB (2015) The nucleus accumbens: an interface between cognition, 
emotion, and action. Annu Rev Psychol 66:25-52. 
Gerfen CR (1992) The neostriatal mosaic: multiple levels of compartmental 
organization. Trends in neurosciences 15:133-139. 
Grace AA, Bunney BS (1984a) The control of firing pattern in nigral 
dopamine neurons: burst firing. The Journal of neuroscience : the official 
journal of the Society for Neuroscience 4:2877-2890. 
Grace AA, Bunney BS (1984b) The control of firing pattern in nigral 
dopamine neurons: single spike firing. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 4:2866-2876. 
Graziane NM, Sun S, Wright WJ, Jang D, Liu Z, Huang YH, Nestler EJ, 
Wang YT, Schluter OM, Dong Y (2016) Opposing mechanisms mediate 
morphine- and cocaine-induced generation of silent synapses. Nature 
neuroscience 19:915-925. 
Grimm JW, Hope BT, Wise RA, Shaham Y (2001) Neuroadaptation. 
Incubation of cocaine craving after withdrawal. Nature 412:141-142. 
Hayes DJ, Jupp B, Sawiak SJ, Merlo E, Caprioli D, Dalley JW (2014) Brain 
gamma-aminobutyric acid: a neglected role in impulsivity. The European 
journal of neuroscience 39:1921-1932. 
Hernandez-Vazquez F, Chavarria K, Garduno J, Hernandez-Lopez S, 
Mihailescu SP (2014) Nicotine increases GABAergic input on rat dorsal 
raphe serotonergic neurons through alpha7 nicotinic acetylcholine receptor. 
Journal of neurophysiology 112:3154-3163. 
Huang YY, Kandel DB, Kandel ER, Levine A (2013) Nicotine primes the 
effect of cocaine on the induction of LTP in the amygdala. 
Neuropharmacology 74:126-134. 
Huttenlocher PR (1979) Synaptic density in human frontal cortex - 
developmental changes and effects of aging. Brain research 163:195-205. 
Julia Morud Lekholm 
 
59 
Ikemoto S, Bonci A (2014) Neurocircuitry of drug reward. 
Neuropharmacology 76 Pt B:329-341. 
Ikemoto S, McBride WJ, Murphy JM, Lumeng L, Li TK (1997) 6-OHDA-
lesions of the nucleus accumbens disrupt the acquisition but not the 
maintenance of ethanol consumption in the alcohol-preferring P line of rats. 
Alcoholism, clinical and experimental research 21:1042-1046. 
Ito R, Hayen A (2011) Opposing roles of nucleus accumbens core and shell 
dopamine in the modulation of limbic information processing. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 31:6001-
6007. 
Jembrek MJ, Vlainic J (2015) GABA Receptors: Pharmacological Potential 
and Pitfalls. Curr Pharm Des 21:4943-4959. 
Kandel D (1975) Stages in adolescent involvement in drug use. Science 
190:912-914. 
Kendler KS, Myers J, Damaj MI, Chen X (2013) Early smoking onset and 
risk for subsequent nicotine dependence: a monozygotic co-twin control 
study. The American journal of psychiatry 170:408-413. 
Khiroug L, Giniatullin R, Talantova M, Nistri A (1997) Role of intracellular 
calcium in fast and slow desensitization of P2-receptors in PC12 cells. British 
journal of pharmacology 120:1552-1560. 
Khiroug L, Sokolova E, Giniatullin R, Afzalov R, Nistri A (1998) Recovery 
from desensitization of neuronal nicotinic acetylcholine receptors of rat 
chromaffin cells is modulated by intracellular calcium through distinct 
second messengers. The Journal of neuroscience : the official journal of the 
Society for Neuroscience 18:2458-2466. 
Kolokotroni KZ, Rodgers RJ, Harrison AA (2011) Acute nicotine increases 
both impulsive choice and behavioural disinhibition in rats. 
Psychopharmacology 217:455-473. 
Koob GF, Le Moal M (2008) Review. Neurobiological mechanisms for 
opponent motivational processes in addiction. Philosophical transactions of 
the Royal Society of London Series B, Biological sciences 363:3113-3123. 
Nicotine sensitization and the effects of extended withdrawal 
60 
Koob GF, Volkow ND (2016) Neurobiology of addiction: a neurocircuitry 
analysis. Lancet Psychiatry 3:760-773. 
Langley JN (1901) On the stimulation and paralysis of nerve-cells and of 
nerve-endings: Part I. The Journal of physiology 27:224-236. 
Langley JN (1918) On the stimulation and paralysis of nerve cells and nerve 
endings: Part II. Paralysis by curari, strychnine and brucine and its 
antagonism by nicotine. The Journal of physiology 52:247-266. 
Laviolette SR, Gallegos RA, Henriksen SJ, van der Kooy D (2004) Opiate 
state controls bi-directional reward signaling via GABAA receptors in the 
ventral tegmental area. Nature neuroscience 7:160-169. 
Le Foll B, Diaz J, Sokoloff P (2003) Increased dopamine D3 receptor 
expression accompanying behavioral sensitization to nicotine in rats. Synapse 
47:176-183. 
Levine A, Huang Y, Drisaldi B, Griffin EA, Jr., Pollak DD, Xu S, Yin D, 
Schaffran C, Kandel DB, Kandel ER (2011) Molecular mechanism for a 
gateway drug: epigenetic changes initiated by nicotine prime gene expression 
by cocaine. Sci Transl Med 3:107ra109. 
Li Y, Kolb B, Robinson TE (2003) The location of persistent amphetamine-
induced changes in the density of dendritic spines on medium spiny neurons 
in the nucleus accumbens and caudate-putamen. Neuropsychopharmacology : 
official publication of the American College of Neuropsychopharmacology 
28:1082-1085. 
Liu IC, Blacker DL, Xu R, Fitzmaurice G, Tsuang MT, Lyons MJ (2004) 
Genetic and environmental contributions to age of onset of alcohol 
dependence symptoms in male twins. Addiction 99:1403-1409. 
Marinelli M, McCutcheon JE (2014) Heterogeneity of dopamine neuron 
activity across traits and states. Neuroscience 282:176-197. 
Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, 
Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, 
Heberlein U, Leonard SS, Levin ED, Lukas RJ, Markou A, Marks MJ, 
McCallum SE, Parameswaran N, Perkins KA, Picciotto MR, Quik M, Rose 
Julia Morud Lekholm 
 
61 
JE, Rothenfluh A, Schafer WR, Stolerman IP, Tyndale RF, Wehner JM, 
Zirger JM (2007) Guidelines on nicotine dose selection for in vivo research. 
Psychopharmacology 190:269-319. 
McGranahan TM, Patzlaff NE, Grady SR, Heinemann SF, Booker TK (2011) 
alpha4beta2 nicotinic acetylcholine receptors on dopaminergic neurons 
mediate nicotine reward and anxiety relief. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 31:10891-10902. 
Miller DK, Wilkins LH, Bardo MT, Crooks PA, Dwoskin LP (2001) Once 
weekly administration of nicotine produces long-lasting locomotor 
sensitization in rats via a nicotinic receptor-mediated mechanism. 
Psychopharmacology 156:469-476. 
Miura M, Ishii K, Aosaki T, Sumikawa K (2006) Chronic nicotine treatment 
increases GABAergic input to striatal neurons. Neuroreport 17:537-540. 
Mody I, Pearce RA (2004) Diversity of inhibitory neurotransmission through 
GABA(A) receptors. Trends in neurosciences 27:569-575. 
Molander A, Soderpalm B (2003) Pre- and postsynaptic dopamine 
mechanisms after repeated nicotine: effects of adrenalectomy. European 
journal of pharmacology 481:51-58. 
Morud J, Adermark L, Ericson M, Soderpalm B (2015) Alterations in 
ethanol-induced accumbal transmission after acute and long-term zinc 
depletion. Addiction biology 20:170-181. 
Nashmi R, Xiao C, Deshpande P, McKinney S, Grady SR, Whiteaker P, 
Huang Q, McClure-Begley T, Lindstrom JM, Labarca C, Collins AC, Marks 
MJ, Lester HA (2007) Chronic nicotine cell specifically upregulates 
functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain 
and enhanced long-term potentiation in perforant path. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 27:8202-
8218. 
Nelson AB, Hammack N, Yang CF, Shah NM, Seal RP, Kreitzer AC (2014) 
Striatal cholinergic interneurons Drive GABA release from dopamine 
terminals. Neuron 82:63-70. 
Nicotine sensitization and the effects of extended withdrawal 
62 
Norton WT, Aquino DA, Hozumi I, Chiu FC, Brosnan CF (1992) 
Quantitative aspects of reactive gliosis: a review. Neurochemical research 
17:877-885. 
Nusser Z, Mody I (2002) Selective modulation of tonic and phasic inhibitions 
in dentate gyrus granule cells. Journal of neurophysiology 87:2624-2628. 
Nusser Z, Sieghart W, Somogyi P (1998) Segregation of different GABAA 
receptors to synaptic and extrasynaptic membranes of cerebellar granule 
cells. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 18:1693-1703. 
Nutt D, King LA, Saulsbury W, Blakemore C (2007) Development of a 
rational scale to assess the harm of drugs of potential misuse. Lancet 
369:1047-1053. 
Obeso JA, Rodriguez-Oroz MC, Benitez-Temino B, Blesa FJ, Guridi J, 
Marin C, Rodriguez M (2008) Functional organization of the basal ganglia: 
therapeutic implications for Parkinson's disease. Movement disorders : 
official journal of the Movement Disorder Society 23 Suppl 3:S548-559. 
Olausson P, Akesson P, Petersson A, Engel JA, Soderpalm B (2001a) 
Behavioral and neurochemical consequences of repeated nicotine treatment 
in the serotonin-depleted rat. Psychopharmacology 155:348-361. 
Olausson P, Engel JA, Soderpalm B (1999) Behavioral sensitization to 
nicotine is associated with behavioral disinhibition; counteraction by 
citalopram. Psychopharmacology 142:111-119. 
Olausson P, Ericson M, Lof E, Engel JA, Soderpalm B (2001b) Nicotine-
induced behavioral disinhibition and ethanol preference correlate after 
repeated nicotine treatment. European journal of pharmacology 417:117-123. 
Olds J, Milner P (1954) Positive reinforcement produced by electrical 
stimulation of septal area and other regions of rat brain. J Comp Physiol 
Psychol 47:419-427. 
Omelchenko N, Sesack SR (2009) Ultrastructural analysis of local collaterals 
of rat ventral tegmental area neurons: GABA phenotype and synapses onto 
dopamine and GABA cells. Synapse 63:895-906. 
Julia Morud Lekholm 
 
63 
Ouagazzal AM, Kenny PJ, File SE (1999) Modulation of behaviour on trials 
1 and 2 in the elevated plus-maze test of anxiety after systemic and 
hippocampal administration of nicotine. Psychopharmacology 144:54-60. 
Paine TA, Olmstead MC (2004) Cocaine disrupts both behavioural inhibition 
and conditional discrimination in rats. Psychopharmacology 175:443-450. 
Paxinos G WC (2007) The Rat Brain in Stereotaxic Coordinates. Academic 
Press Inc: San Diego, CA. 
Perna G, Alciati A, Riva A, Micieli W, Caldirola D (2016) Long-Term 
Pharmacological Treatments of Anxiety Disorders: An Updated Systematic 
Review. Curr Psychiatry Rep 18:23. 
Pettit HO, Ettenberg A, Bloom FE, Koob GF (1984) Destruction of dopamine 
in the nucleus accumbens selectively attenuates cocaine but not heroin self-
administration in rats. Psychopharmacology 84:167-173. 
Picciotto MR, Addy NA, Mineur YS, Brunzell DH (2008) It is not 
"either/or": activation and desensitization of nicotinic acetylcholine receptors 
both contribute to behaviors related to nicotine addiction and mood. Progress 
in neurobiology 84:329-342. 
Pidoplichko VI, DeBiasi M, Williams JT, Dani JA (1997) Nicotine activates 
and desensitizes midbrain dopamine neurons. Nature 390:401-404. 
Pidoplichko VI, Noguchi J, Areola OO, Liang Y, Peterson J, Zhang T, Dani 
JA (2004) Nicotinic cholinergic synaptic mechanisms in the ventral 
tegmental area contribute to nicotine addiction. Learning & memory 11:60-
69. 
Placzek AN, Zhang TA, Dani JA (2009) Age dependent nicotinic influences 
over dopamine neuron synaptic plasticity. Biochemical pharmacology 
78:686-692. 
Posselt W, Reimann, L. (1828) Chemische Untersuchung des Tabaks und 
Darstellung eines eigenthümlich wirksamen Prinzips dieser Pflanze 
(Chemical investigation of tobacco and preparation of a characteristically 
active constituent of this plant). 
Nicotine sensitization and the effects of extended withdrawal 
64 
Quick MW, Lester RA (2002) Desensitization of neuronal nicotinic 
receptors. J Neurobiol 53:457-478. 
Rahman S, McBride WJ (2002) Involvement of GABA and cholinergic 
receptors in the nucleus accumbens on feedback control of somatodendritic 
dopamine release in the ventral tegmental area. Journal of neurochemistry 
80:646-654. 
Rassnick S, Stinus L, Koob GF (1993) The effects of 6-hydroxydopamine 
lesions of the nucleus accumbens and the mesolimbic dopamine system on 
oral self-administration of ethanol in the rat. Brain research 623:16-24. 
Robinson TE, Berridge KC (1993) The neural basis of drug craving: an 
incentive-sensitization theory of addiction. Brain research Brain research 
reviews 18:247-291. 
Rostron BL, Chang CM, Pechacek TF (2014) Estimation of cigarette 
smoking-attributable morbidity in the United States. JAMA Intern Med 
174:1922-1928. 
Russo SJ, Nestler EJ (2013) The brain reward circuitry in mood disorders. 
Nat Rev Neurosci 14:609-625. 
Salamone JD (1994) The involvement of nucleus accumbens dopamine in 
appetitive and aversive motivation. Behavioural brain research 61:117-133. 
Schilstrom B, Nomikos GG, Nisell M, Hertel P, Svensson TH (1998) N-
methyl-D-aspartate receptor antagonism in the ventral tegmental area 
diminishes the systemic nicotine-induced dopamine release in the nucleus 
accumbens. Neuroscience 82:781-789. 
Schultz W (2006) Behavioral theories and the neurophysiology of reward. 
Annu Rev Psychol 57:87-115. 
Schultz W, Dayan P, Montague PR (1997) A neural substrate of prediction 
and reward. Science 275:1593-1599. 
Schuster CR, Thompson T (1969) Self administration of and behavioral 
dependence on drugs. Annu Rev Pharmacol 9:483-502. 
Julia Morud Lekholm 
 
65 
Semyanov A, Walker MC, Kullmann DM (2003) GABA uptake regulates 
cortical excitability via cell type-specific tonic inhibition. Nature 
neuroscience 6:484-490. 
Shram MJ, Funk D, Li Z, Le AD (2006) Periadolescent and adult rats 
respond differently in tests measuring the rewarding and aversive effects of 
nicotine. Psychopharmacology 186:201-208. 
Sihver W, Nordberg A, Langstrom B, Mukhin AG, Koren AO, Kimes AS, 
London ED (2000) Development of ligands for in vivo imaging of cerebral 
nicotinic receptors. Behavioural brain research 113:143-157. 
Skrede KK, Westgaard RH (1971) The transverse hippocampal slice: a well-
defined cortical structure maintained in vitro. Brain research 35:589-593. 
Soderpalm B, Engel JA (1990) Serotonergic involvement in conflict 
behaviour. Eur Neuropsychopharmacol 1:7-13. 
Soltesz I, Roberts JD, Takagi H, Richards JG, Mohler H, Somogyi P (1990) 
Synaptic and Nonsynaptic Localization of Benzodiazepine/GABAA 
Receptor/Cl- Channel Complex Using Monoclonal Antibodies in the Dorsal 
Lateral Geniculate Nucleus of the Cat. The European journal of neuroscience 
2:414-429. 
Staley JK, Krishnan-Sarin S, Cosgrove KP, Krantzler E, Frohlich E, Perry E, 
Dubin JA, Estok K, Brenner E, Baldwin RM, Tamagnan GD, Seibyl JP, 
Jatlow P, Picciotto MR, London ED, O'Malley S, van Dyck CH (2006) 
Human tobacco smokers in early abstinence have higher levels of beta2* 
nicotinic acetylcholine receptors than nonsmokers. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 26:8707-
8714. 
SverigesRegering (2016) Budgetpropositionen för 2016 (proposition 
2015/16:1) och vårbudgeten 2016. 
Tepper JM, Plenz D (2006) Microcircuits in the striatum: striatal cell types 
and their interaction. Microcircuits: the interface between neurons and global 
brain function The MIT Press, Massachusetts, Cambridge:127-148. 
Nicotine sensitization and the effects of extended withdrawal 
66 
Thiel CM, Muller CP, Huston JP, Schwarting RKW (1999) High versus low 
reactivity to a novel environment: Behavioural, pharmacological and 
neurochemical assessments. Neuroscience 93:243-251. 
Tolu S, Eddine R, Marti F, David V, Graupner M, Pons S, Baudonnat M, 
Husson M, Besson M, Reperant C, Zemdegs J, Pages C, Hay YA, Lambolez 
B, Caboche J, Gutkin B, Gardier AM, Changeux JP, Faure P, Maskos U 
(2013) Co-activation of VTA DA and GABA neurons mediates nicotine 
reinforcement. Mol Psychiatry 18:382-393. 
Tomko RL, Bountress KE, Gray KM (2016) Personalizing substance use 
treatment based on pre-treatment impulsivity and sensation seeking: A 
review. Drug Alcohol Depend 167:1-7. 
Trudeau LE, Hnasko TS, Wallen-Mackenzie A, Morales M, Rayport S, 
Sulzer D (2014) The multilingual nature of dopamine neurons. Progress in 
brain research 211:141-164. 
Tunstall MJ, Oorschot DE, Kean A, Wickens JR (2002) Inhibitory 
interactions between spiny projection neurons in the rat striatum. Journal of 
neurophysiology 88:1263-1269. 
Vallejo YF, Buisson B, Bertrand D, Green WN (2005) Chronic nicotine 
exposure upregulates nicotinic receptors by a novel mechanism. The Journal 
of neuroscience : the official journal of the Society for Neuroscience 
25:5563-5572. 
Vargas-Perez H, Ting AKR, Walton CH, Hansen DM, Razavi R, Clarke L, 
Bufalino MR, Allison DW, Steffensen SC, van der Kooy D (2009) Ventral 
tegmental area BDNF induces an opiate-dependent-like reward state in naive 
rats. Science 324:1732-1734. 
Vernino S, Amador M, Luetje CW, Patrick J, Dani JA (1992) Calcium 
modulation and high calcium permeability of neuronal nicotinic acetylcholine 
receptors. Neuron 8:127-134. 
Vezina P (1996) D1 dopamine receptor activation is necessary for the 
induction of sensitization by amphetamine in the ventral tegmental area. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 
16:2411-2420. 
Julia Morud Lekholm 
 
67 
Vicente AM, Galvao-Ferreira P, Tecuapetla F, Costa RM (2016) Direct and 
indirect dorsolateral striatum pathways reinforce different action strategies. 
Curr Biol 26:R267-269. 
Vieira-Brock PL, Andrenyak DM, Nielsen SM, Fleckenstein AE, Wilkins 
DG (2013) Age-related differences in the disposition of nicotine and 
metabolites in rat brain and plasma. Nicotine Tob Res 15:1839-1848. 
Voorn P, Gerfen CR, Groenewegen HJ (1989) Compartmental organization 
of the ventral striatum of the rat: immunohistochemical distribution of 
enkephalin, substance P, dopamine, and calcium-binding protein. The Journal 
of comparative neurology 289:189-201. 
Waddell S (2013) Reinforcement signalling in Drosophila; dopamine does it 
all after all. Current opinion in neurobiology 23:324-329. 
Walf AA, Frye CA (2007) The use of the elevated plus maze as an assay of 
anxiety-related behavior in rodents. Nat Protoc 2:322-328. 
WHO (2015) World Health Organization Report on the Global Tobacco 
Epidemic. 
Wise RA (1996) Addictive drugs and brain stimulation reward. Annu Rev 
Neurosci 19:319-340. 
Wonnacott S (1990) The paradox of nicotinic acetylcholine receptor 
upregulation by nicotine. Trends Pharmacol Sci 11:216-219. 
Wroth LC, Dickson SA (1955) Panacea or Precious Bane; Tobacco in 
Sixteenth Century Literature. JSTOR. 
Xiao C, Nashmi R, McKinney S, Cai H, McIntosh JM, Lester HA (2009) 
Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine 
receptors in the nigrostriatal dopamine pathway. The Journal of neuroscience 
: the official journal of the Society for Neuroscience 29:12428-12439. 
Yamaguchi K, Kandel DB (1984) Patterns of drug use from adolescence to 
young adulthood: II. Sequences of progression. Am J Public Health 74:668-
672. 
Nicotine sensitization and the effects of extended withdrawal 
68 
Yokel RA, Wise RA (1975) Increased lever pressing for amphetamine after 
pimozide in rats: implications for a dopamine theory of reward. Science 
187:547-549. 
Zhang L, Dong Y, Doyon WM, Dani JA (2012) Withdrawal from chronic 
nicotine exposure alters dopamine signaling dynamics in the nucleus 
accumbens. Biological psychiatry 71:184-191. 
Zhang T, Zhang L, Liang Y, Siapas AG, Zhou FM, Dani JA (2009) 
Dopamine signaling differences in the nucleus accumbens and dorsal striatum 
exploited by nicotine. The Journal of neuroscience : the official journal of the 
Society for Neuroscience 29:4035-4043. 
Zoli M, Pistillo F, Gotti C (2015) Diversity of native nicotinic receptor 
subtypes in mammalian brain. Neuropharmacology 96:302-311. 
 
